DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	EVPLL; FOXN1; SCEL; KRT14; PTHLH; KRT5; KRT15; SPRR1B; SPRR2E; SPRR2D; S100A7; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KLK7; BNC1; KRT32; KRT31; ZNF750; GRHL2; ACER1; SPRR2F; CALML5; SPRR3; KLK5; KRTDAP;	GO:0008544~epidermis development	28	82	34.1463414634146	0	0	0	0	0	0	0
up	KRT33A; KRT14; KRT6A; KRT6B; KRT16; KRT3; KRT13; KRT5; KRT15; KRT4; CDH3; DSG3; KRT9; KRT6C; DSG1; TGM3; PKP1; KRT32; KRT31; KRT24; LCE3E; LCE3A; KRT80; DSG4; KRT78; KRTAP3-2;	GO:0031424~keratinization	26	181	14.3646408839779	0	0	0	0	0	0	0
up	KRT33A; KRT14; KRT6A; KRT6B; IVL; KRT16; KRT3; KRT13; KRT5; KRT15; KRT4; SPRR1B; SPRR2E; SPRR2D; DSG3; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT6C; DSG1; PKP1; KRT32; KRT31; KRT24; LIPK; KRT80; RPTN; DSG4; KRT78; SPRR2F; LCE3D; SPINK5; SPRR3; KLK12; KLK13; KLK5;	GO:0070268~cornification	37	113	32.7433628318584	0	0	0	0	0	0	0
down	TRAV2; IGLV3-21; IGKV3-11; IGLV7-46; IGLV5-45; IGLV3-19; IGLV2-14; TRDV2; IGKV1-9; IGKV2D-29; IGLV2-23; IGKV3-20; IGKV2-24; IGLV2-8; IGKV1-8; IGKV4-1; IGKV1-16; TRAV14DV4; IGLV2-11; TRDV1; IGKV1-27; IGKV1-12; IGLV1-40; TRAV38-2DV8; IGLV3-1; IGLV1-44; IGKV1-5; IGLV8-61; IGLV7-43; IGKV2-30; TRAV9-2; TRAV19; IGLV1-47; IGKV3-15;	GO:0002377~immunoglobulin production	34	107	31.7757009345794	0	0	0	0	0	0	0
down	ABCC4; F13A1; CFD; A2M; TIMP1; FN1; ORM1; PPBP; PF4; APP; SERPINE1; SERPING1; PROS1; THBS1; SPARC; CLU; HGF; SELP; ORM2; TIMP3; CTSW; LGALS3BP; MMRN1; MAGED2;	GO:0002576~platelet degranulation	24	124	19.3548387096774	0	0	0	0	0	0	0
down	IGKV1-12; HP; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; APOE; IGLV7-43; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; SPARC; IGLC3; FOLR2; IGHV1-2; FCGR2B; HBA1; IGLV3-21; HSPG2; DNM1; FCGR1B; PDLIM7; DAB2;	GO:0006898~receptor-mediated endocytosis	42	160	26.25	0	0	0	0	0	0	0
down	FCGR2B; AIF1; MFGE8; IGHG2; IGHV1-2; IGHV3-30; IGHV3-53; IGHV3-7; IGHV3-43; IGHV3-21; IGHV2-5; TRDC; TRBC2; IGHV4-39; IGHV3-49; IGHV1-3; IGHV1-46; IGHV4-59; IGHV3-15; IGHV1-69-2; IGHV6-1; IGHV3-48; IGHV4-34; IGLC3; IGHV5-51; IGHV1-18; IGHD; IGLL5; TRBC1; IGHV3-23;	GO:0006911~phagocytosis, engulfment	30	115	26.0869565217391	0	0	0	0	0	0	0
down	IGKV1-12; FCN1; C1R; CFD; C3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGHG2; IGLV7-43; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; C2; CFH; C1S; IGLC3; C7; CLU; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	41	92	44.5652173913043	0	0	0	0	0	0	0
down	IGKV1-12; C1R; C3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGHG2; C4BPA; IGLV7-43; IGKV1-16; IGKV3-11; SERPING1; IGKV2-30; IGKV4-1; IGHV4-34; C2; C1S; IGLC3; C7; CLU; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV3-21; IGHV5-51; IGHD; IGHV1-69-2; IGHV3-49; TRBC2; IGLL5; IGHV3-15; TRBC1; IGHV6-1; IGHV1-3; IGHV3-43;	GO:0006958~complement activation, classical pathway	54	161	33.5403726708075	0	0	0	0	0	0	0
down	TGFB1I1; EDIL3; FN1; APP; LAMB1; THBS1; LAMC1; COL6A1; COL6A2; COL6A3; NCAM1; GP9; SELP; ITGB4; ENG; VCAM1; COL5A1; TNXB; LAMA2; ACKR3; GP5; MCAM; CXCL12; CXCR3; BMX; MFAP4; SRPX; COL16A1; SCN1B; LGALS3BP; MFGE8; SPOCK1; MMRN1; MYBPH; SLAMF1; PTK7; LSAMP; SEMA5A; LAMC2; COL4A6; ADGRE1; MYBPC3; COL19A1; PTPRK; IGFBP7; LAMA4; DDR2; AOC3; SVEP1; FBLN7; CERCAM; NEO1; FEZ1; MXRA8; SIRPG; CD300A; ITGA11; CLEC4A; TLN2; LOXL2; EMILIN1; ROBO1; NINJ2; SIGLEC5; SIGLEC10; ICAM2; SIGLEC14; PCDH9; SPON2; SPON1; SIGLEC7; ICAM3; NINJ1; TGFBI;	GO:0007155~cell adhesion	74	454	16.2995594713656	0	0	0	0	0	0	0
down	TNFRSF13B; LILRA1; IFNG; IL2RA; CD3D; INHBA; CD3G; IFITM1; IL1R1; CXCR1; CD27; IFNAR2; CXCR3; GEM; ADGRE1; LILRB2; KLRG1; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; TRBV6-1; TRBV27; TRBV7-3; TRBV5-5; TRBV3-1; TRBV2; TRBV28; TRBV6-2; TRBV25-1; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV15; TRBV30; TRBV4-2; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-6; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	51	268	19.0298507462687	0	0	0	0	0	0	0
down	SOCS3; LAMA5; F13A1; TIMP1; FOS; IL2RA; FN1; PF4; MMP1; FCER2; COL1A2; MMP2; CXCL1; CSF1; OSM; HGF; IL1R1; ALOX15; JUNB; VCAM1; CXCL2; PTPN6; CCR2; FASLG; IL5RA; IL11RA; IRF4; BATF; IL34; NDN; OSMR; F3; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	33	278	11.8705035971223	0	0	0	0	0	0	0
down	LAMA5; COL1A1; COL3A1; FN1; APP; SERPINE1; COL5A2; LAMB1; THBS1; COL1A2; COL4A2; SPARC; LAMC1; COL6A1; COL6A2; COL6A3; ICAM2; NID1; ITGB4; PDGFRA; VCAM1; COL5A1; FBLN1; LAMA2; ICAM3; FBN1; FBN2; LAMB2; ITGA1; FBLN2; HSPG2; COL16A1; LOXL1; ITGAD; LAMB3; LAMC2; COL4A6; COL19A1; LAMA4; LAMA3; DDR2; OLFML2A; NPNT; CCDC80; ABI3BP; PXDN; JAM3; CRISPLD2; FBLN5; ITGA11; LAMC3; COL27A1; MMP2; MMP11; TGFBI; MMP8; MMP1; MMP17; MMP19; RECK;	GO:0030198~extracellular matrix organization	60	230	26.0869565217391	0	0	0	0	0	0	0
down	IGKV1-12; C1R; C3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGHG2; C4BPA; IGLV7-43; IGKV1-16; IGKV3-11; SERPING1; IGKV2-30; IGKV4-1; IGHV4-34; C2; PROS1; CFH; C1S; IGLC3; C7; CLU; CD19; IGHV1-2; CD81; IGLV3-21;	GO:0030449~regulation of complement activation	44	113	38.9380530973451	0	0	0	0	0	0	0
down	IGKV1-12; FOS; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGLV7-43; IGKV1-16; IGKV3-11; JUN; IGKV2-30; IGKV4-1; IGHV4-34; IGLC3; IGHV1-2; PSMB8; PSMB9; PSMB10; MAPK10; LILRA4; IGLV3-21;	GO:0038095~Fc-epsilon receptor signaling pathway	38	171	22.2222222222222	0	0	0	0	0	0	0
down	IGKV1-12; ARPC1B; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGHG2; IGLV7-43; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; CD3G; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; ACTB; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	38	135	28.1481481481481	0	0	0	0	0	0	0
down	HP; PPBP; ISG15; GNLY; CAMP; CXCL6; S100A12; IRF8; CEBPE; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHV1-46; IGHV3-53; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV1-18; IGHV3-7; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-23; IGHV1-69-2; TRDC; IGHV3-43; IGHV4-39; IGHV3-21; GSDMD; IGHV4-59; IGHV1-3;	GO:0042742~defense response to bacterium	37	216	17.1296296296296	0	0	0	0	0	0	0
down	SOCS3; WFS1; PRSS23; FSTL3; CP; C3; TIMP1; APOE; FN1; APP; LAMB1; LGALS1; CSF1; LAMC1; BMP4; IGFBP3; IGFBP4; IGFBP5; PSMB8; PSMB9; SDC2; FBN1; PSMB10; LAMB2; MFGE8; FSTL1; SPARCL1; LTBP1; RCN1; IGFBP7; FAM20C; SHISA5; EPAS1; MXRA8;	GO:0043687~post-translational protein modification	34	344	9.88372093023256	0	0	0	0	0	0	0
down	WFS1; PRSS23; FSTL3; CP; C3; TIMP1; APOE; FN1; MMP1; APP; LAMB1; MMP2; LGALS1; CSF1; LAMC1; BMP4; IGFBP3; IGFBP4; IGFBP6; IGFBP5; SDC2; FBN1; LAMB2; B2M; HSPG2; MFGE8; FSTL1; PAPPA; SPARCL1; LTBP1; RCN1; TGFBI; IGFBP7; TSPAN33; FAM20C; SHISA5; MXRA8; LMCD1;	GO:0044267~cellular protein metabolic process	38	200	19	0	0	0	0	0	0	0
down	TRGV8; TRGV4; TRDV1; TRDV2; LILRA5; CD300LB; TYROBP; PGLYRP1; LY86; C1R; TRGV3; C4BPA; APP; SERPING1; C2; CSF1; C1S; CLU; RNASE3; DEFA4; AXL; KIR2DS4; GSDMD; NLRP6; LILRA4; B2M; S100A12; SIGLEC14; NAIP; SLAMF1; CD300E; TREML4; IL34; TREML1; LILRA2; CLEC4C; RNASE6; PLD4; KLRG1; SIGLEC10; CD180; TRGV9; CNPY3; SPON2; TLR8; APOBEC3C; TLR7; MSRB1; CD84; CLEC4A; TRDC; IGHV3-15; IGHV3-48; IGHV1-69-2; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV3-53; IGHV1-3; TRBC2; IGHV3-30; IGLC3; IGHV3-49; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV3-7; IGHV1-18; IGHV1-46; IGLL5; BPI; IGHV4-34; IGHV2-5; IGHD; IGHG2; CAMP; IGHV3-43;	GO:0045087~innate immune response	79	505	15.6435643564356	0	0	0	0	0	0	0
down	TRAV19; IGKV1-12; CD300LB; NCR3; TYROBP; LILRA1; NCR1; C3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; TRBV12-3; TRAV8-4; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; TRBC1; COL1A1; COL3A1; IGLV7-43; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV2-30; IGKV4-1; IGHV4-34; COL1A2; CD3G; IGLC3; CD8B; IFITM1; ICAM2; CD19; HLA-G; VCAM1; IGHV1-2; CD40LG; FCGR2B; ICAM3; CD200; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; CD81; B2M; IGLV3-21; CD300E; TREML2; CD276; TREML4; TREML1; LILRB2; LILRB1; CD300LF; HCST; CD300A; SIGLEC7; BTNL8; BTNL3;	GO:0050776~regulation of immune response	77	216	35.6481481481481	0	0	0	0	0	0	0
down	MS4A1; CD19; PTPN6; MNDA; NCKAP1L; IGHV4-34; IGHV3-21; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-5; IGLL5; IGLC3; IGHV3-43; IGHV3-30; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-46; IGHV4-59; IGHV6-1; IGHV1-18; LCK; TRBC1; TRDC; IGHD; IGHV3-15; IGHV3-48; IGHV3-53; IGHV3-49; IGHV3-7;	GO:0050853~B cell receptor signaling pathway	34	125	27.2	0	0	0	0	0	0	0
down	IGKV1-12; SDC3; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGHV1-46; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; COL1A1; FN1; MMP1; IGLV7-43; IGKV1-16; IGKV3-11; LCK; IGKV2-30; IGKV4-1; IGHV4-34; PROS1; COL1A2; CD48; IGLC3; SELP; IGHV1-2; PTPN6; CEACAM8; SDC2; CEACAM3; IGLV3-21; JAM3; SIRPG; CD84;	GO:0050900~leukocyte migration	47	193	24.3523316062176	0	0	0	0	0	0	0
down	EMP3; PMP22; MYLK; LPAR1;	GO:0032060~bleb assembly	4	10	40	0.00010656790432039	0.0019453058335613	0.332918133096924	0.352100355874596	0.241789641051454	0.332918133096924	0.0168857528740993
down	TYROBP; ALOX15; TGM2; AXL; MFGE8;	GO:0043277~apoptotic cell clearance	5	21	23.8095238095238	0.00010970678477051	0.00199160009275702	0.342614288838314	0.362471216881777	0.24574319788595	0.342614288838314	0.0172875989009717
down	LILRA5; ORM1; ORM2; GSDMD; LILRA2; TLR8;	GO:0050718~positive regulation of interleukin-1 beta secretion	6	35	17.1428571428571	0.00011103366789877	0.00200467343572432	0.346647111179974	0.366855238737551	0.247383012078469	0.346647111179974	0.0174010788663199
up	CIDEA; EDN2; ACADL; NMU;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.00011116054181625	0.00450951279097845	0.162961354302634	0.166851973266203	0.153009953640611	0.162850193760817	0.035586529645734
up	KRT16; KRT3; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	4	22	18.1818181818182	0.00011116054181625	0.00450951279097845	0.162961354302634	0.166851973266203	0.153009953640611	0.162850193760817	0.035586529645734
down	C3; VIL1; MS4A1; GZMA; FCGR2B; CD79B; NEXN; CCDC80; NLRP6;	GO:0009617~response to bacterium	9	92	9.78260869565217	0.00012565426668942	0.00222556500768232	0.392041312071001	0.415161697141855	0.264376577114547	0.392041312071001	0.0193184742864661
down	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0001266362655703	0.00222556500768232	0.39497851231377	0.418406221444275	0.265429612635351	0.394725239782629	0.0193184742864661
down	LCK; MDK; SKAP1;	GO:1903039~positive regulation of leukocyte cell-cell adhesion	3	3	100	0.0001266362655703	0.00222556500768232	0.39497851231377	0.418406221444275	0.265429612635351	0.394725239782629	0.0193184742864661
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0001266362655703	0.00222556500768232	0.39497851231377	0.418406221444275	0.265429612635351	0.394725239782629	0.0193184742864661
down	CD3G; ACTB; PARVA; RHOBTB2; RHOBTB1; PARVG; RHOBTB3;	GO:0007163~establishment or maintenance of cell polarity	7	53	13.2075471698113	0.00013133851641644	0.00223513690751531	0.409119478637229	0.433942458239938	0.270688682334295	0.408988140120813	0.0194015608286062
down	MMP8; SCIMP; LILRB2; SPON2; ZBTB20; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	7	53	13.2075471698113	0.00013133851641644	0.00223513690751531	0.409119478637229	0.433942458239938	0.270688682334295	0.408988140120813	0.0194015608286062
down	IFNG; CSF1; BMP4; SPI1; CEBPE;	GO:0030225~macrophage differentiation	5	22	22.7272727272727	0.00013256196936417	0.00223513690751531	0.412665410630678	0.437984746779236	0.272018390730646	0.412231224730981	0.0194015608286062
down	APOD; MDK; NINJ1; NINJ2; CPQ;	GO:0042246~tissue regeneration	5	22	22.7272727272727	0.00013256196936417	0.00223513690751531	0.412665410630678	0.437984746779236	0.272018390730646	0.412231224730981	0.0194015608286062
down	C3; SERPINE1; CLU; B2M; SGIP1;	GO:0048260~positive regulation of receptor-mediated endocytosis	5	22	22.7272727272727	0.00013256196936417	0.00223513690751531	0.412665410630678	0.437984746779236	0.272018390730646	0.412231224730981	0.0194015608286062
down	THBS1; VIL1; HGF; CD27; CDKN2D; BEX3; NAIP; CARD16;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	8	72	11.1111111111111	0.00013259286739497	0.00223513690751531	0.412665410630678	0.438086833873001	0.272080563894491	0.412231224730981	0.0194015608286062
down	IFNG; NCAM1; HLA-G; VCAM1; B2M; IRF8; IRF4; FCGR1B;	GO:0060333~interferon-gamma-mediated signaling pathway	8	72	11.1111111111111	0.00013259286739497	0.00223513690751531	0.412665410630678	0.438086833873001	0.272080563894491	0.412231224730981	0.0194015608286062
up	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.0001419589394922	0.00548798432394652	0.207827887416586	0.213080368177798	0.182843114065959	0.207827887416586	0.0433080747060198
down	AIP; PDE4A; AKAP12; AKAP7;	GO:0010738~regulation of protein kinase A signaling	4	11	36.3636363636364	0.00014315772704265	0.00235319965248222	0.444934215648566	0.472993130148926	0.283881772725581	0.444361584740395	0.0204263756935775
down	IFITM1; IFNAR2; IFITM3; IFITM2;	GO:0035455~response to interferon-alpha	4	11	36.3636363636364	0.00014315772704265	0.00235319965248222	0.444934215648566	0.472993130148926	0.283881772725581	0.444361584740395	0.0204263756935775
down	IFITM1; IFNAR2; IFITM3; IFITM2;	GO:0035456~response to interferon-beta	4	11	36.3636363636364	0.00014315772704265	0.00235319965248222	0.444934215648566	0.472993130148926	0.283881772725581	0.444361584740395	0.0204263756935775
down	DDR2; COL1A1; COL4A6; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	4	11	36.3636363636364	0.00014315772704265	0.00235319965248222	0.444934215648566	0.472993130148926	0.283881772725581	0.444361584740395	0.0204263756935775
down	JUN; CSF1; ZFP36L1; IL34;	GO:0045657~positive regulation of monocyte differentiation	4	11	36.3636363636364	0.00014315772704265	0.00235319965248222	0.444934215648566	0.472993130148926	0.283881772725581	0.444361584740395	0.0204263756935775
down	JUN; BMP4; F3; NR4A1; ACVRL1; CXCL12; SEMA5A; PGF;	GO:0001938~positive regulation of endothelial cell proliferation	8	73	10.958904109589	0.00014472263989628	0.00236714654563038	0.449074351598184	0.478163602217338	0.285537768515377	0.449074351598184	0.0205474382982324
down	LILRA5; IFNG; F2R; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.00014582015682451	0.00237334875935075	0.45233412646965	0.481789798148203	0.286682428317	0.45233412646965	0.0206012751018587
down	FLRT2; COL5A1; PTCH1; MYBPC3; FAT4; DLC1;	GO:0003007~heart morphogenesis	6	38	15.7894736842105	0.00016617480481828	0.00267617535987133	0.515308069741506	0.549041555119619	0.305096941646374	0.515141894936688	0.0232298875554248
down	TYROBP; FOS; IFNG; CLU; EGR1; FCGR2B;	GO:1901216~positive regulation of neuron death	6	38	15.7894736842105	0.00016617480481828	0.00267617535987133	0.515308069741506	0.549041555119619	0.305096941646374	0.515141894936688	0.0232298875554248
up	IL36A; IL36RN; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	4	25	16	0.00017257166201478	0.00631780645571206	0.252299769865618	0.259030064684195	0.208811711037892	0.252127198203603	0.0498565625940768
up	CYP2C9; CYP4B1; CYP2C19; CYP2C18;	GO:0042738~exogenous drug catabolic process	4	25	16	0.00017257166201478	0.00631780645571206	0.252299769865618	0.259030064684195	0.208811711037892	0.252127198203603	0.0498565625940768
down	CILP; COL1A1; COL4A2; FBN1; ACVRL1; ZFP36L1; PDGFD;	GO:0071560~cellular response to transforming growth factor beta stimulus	7	56	12.5	0.00017921234211471	0.00286047139298068	0.55519983587137	0.592117578347001	0.316668208516692	0.55519983587137	0.0248296243253825
up	EGFR; DSG1; CRNN; DSG4; DSG3; CDH13; CDH3; PKP1;	GO:0098609~cell-cell adhesion	8	152	5.26315789473684	0.00018549822686131	0.00655943388181362	0.270827411217518	0.278432838518832	0.218863982091825	0.270827411217518	0.051763349859297
up	FGF1; PTN; WNT3A;	GO:2000347~positive regulation of hepatocyte proliferation	3	9	33.3333333333333	0.00018791183005861	0.00655943388181362	0.274163360055524	0.282055656917986	0.220660799741414	0.274163360055524	0.051763349859297
down	IL2RA; COL3A1; HLA-G; FCGR2B;	GO:0050777~negative regulation of immune response	4	12	33.3333333333333	0.00018803883747775	0.00294603926933874	0.582356279668608	0.621280319026503	0.323802878136695	0.58216824083113	0.0255723754081254
down	TYROBP; FAM107A; APOE; APP;	GO:1900272~negative regulation of long-term synaptic potentiation	4	12	33.3333333333333	0.00018803883747775	0.00294603926933874	0.582356279668608	0.621280319026503	0.323802878136695	0.58216824083113	0.0255723754081254
down	ISG15; BMP4; FBN2; GPM6B; PKDCC; FAM20C;	GO:0030501~positive regulation of bone mineralization	6	39	15.3846153846154	0.00018870969155693	0.00294603926933874	0.584056495368704	0.623496820904103	0.324391959786366	0.584056495368704	0.0255723754081254
down	PF4; IRF8; IRF4; BATF; BATF2;	GO:0042832~defense response to protozoan	5	24	20.8333333333333	0.0001890315753934	0.00294603926933874	0.584863694267197	0.624560325099813	0.324618360017093	0.584674662691804	0.0255723754081254
down	DLL1; CXCL14; BMP4; ID3; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.0001890315753934	0.00294603926933874	0.584863694267197	0.624560325099813	0.324618360017093	0.584674662691804	0.0255723754081254
down	CEACAM4; AXL; ICAM3; IRF8; SLAMF1; CEBPE; PLD4;	GO:0006909~phagocytosis	7	57	12.280701754386	0.000197983965039	0.00307107521356279	0.612166419900606	0.654139020488875	0.331821125405374	0.612166419900606	0.0266577194286499
down	RECK; MMP2; FBLN1; FUT7; TRO; IGFBP7;	GO:0007566~embryo implantation	6	40	15	0.00021358746341559	0.00328229292616343	0.6599852619542	0.705692979125138	0.344302991025945	0.6599852619542	0.0284911432718702
down	FBN1; FBN2; LTBP1;	GO:0035583~sequestering of TGFbeta in extracellular matrix	3	4	75	0.00021850883086105	0.00332697316665861	0.674973778529792	0.721953177164918	0.348303076392518	0.674755269698931	0.0288789792030336
down	APOE; APP; CLU;	GO:1905908~positive regulation of amyloid fibril formation	3	4	75	0.00021850883086105	0.00332697316665861	0.674973778529792	0.721953177164918	0.348303076392518	0.674755269698931	0.0288789792030336
down	RNASE2; RNASE3; RNASEH2C; RNASE6; ISG20;	GO:0006401~RNA catabolic process	5	25	20	0.0002233416389229	0.00338495768349207	0.689455639355	0.73792077500127	0.352209764581417	0.689455639355	0.0293822996603528
up	GABRR1; GABRA4; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	4	27	14.8148148148148	0.00022513319595374	0.00754488950515944	0.328244199700555	0.337924927126566	0.249222447920792	0.328244199700555	0.0595400094188195
up	EGFR; KRT6A; FGF1; CDH3; SPRR3; EVPLL;	GO:0042060~wound healing	6	82	7.31707317073171	0.00022619588789618	0.00754488950515944	0.329567408664742	0.339520027732175	0.250048996985816	0.329567408664742	0.0595400094188195
down	DLL1; APP; GLI3; PBX1; ID2; OLIG2; DIXDC1;	GO:0045665~negative regulation of neuron differentiation	7	59	11.864406779661	0.00024028556509248	0.00357308558698788	0.741521253875392	0.793903507065552	0.365714630070754	0.741521253875392	0.0310152980466976
down	CFD; C3; CFH; C7;	GO:0006957~complement activation, alternative pathway	4	13	30.7692307692308	0.00024224309064324	0.00357308558698788	0.747319934634414	0.800371171485285	0.367331678188701	0.746350962271841	0.0310152980466976
down	SLIT2; SERPINE1; IGFBP3; IGFBP5;	GO:0014912~negative regulation of smooth muscle cell migration	4	13	30.7692307692308	0.00024224309064324	0.00357308558698788	0.747319934634414	0.800371171485285	0.367331678188701	0.746350962271841	0.0310152980466976
down	CD19; CD27; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	4	13	30.7692307692308	0.00024224309064324	0.00357308558698788	0.747319934634414	0.800371171485285	0.367331678188701	0.746350962271841	0.0310152980466976
down	VIL1; ID1; SYNPO; SYNPO2;	GO:0032233~positive regulation of actin filament bundle assembly	4	13	30.7692307692308	0.00024224309064324	0.00357308558698788	0.747319934634414	0.800371171485285	0.367331678188701	0.746350962271841	0.0310152980466976
down	PF4; CSF1; ID2; IL34;	GO:0045651~positive regulation of macrophage differentiation	4	13	30.7692307692308	0.00024224309064324	0.00357308558698788	0.747319934634414	0.800371171485285	0.367331678188701	0.746350962271841	0.0310152980466976
down	TERT; DPM2; FAM107A; CD81; ANK2; SOX4; INSC; TMEM25;	GO:0031647~regulation of protein stability	8	80	10	0.00025777877767829	0.00378533813977375	0.793958635249155	0.851701081449093	0.376616992718075	0.793958635249155	0.0328577045677728
down	IFNG; HLA-G; CD40LG; IRF8; SCIMP;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.00026218956647294	0.00383307224613549	0.807281675170207	0.86627432762662	0.379126113119883	0.807281675170207	0.0332720488368251
down	TGFB1I1; COL1A1; BMP4; MDK; DAB2; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	6	42	14.2857142857143	0.00027105469999333	0.0039452190695065	0.834306366579482	0.895564728777975	0.384084509890554	0.834306366579482	0.0342455119871368
down	IL2RA; HLA-G; PTPN6; LILRB2; LILRB1; MAD1L1;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.00030400176558154	0.00438612154358695	0.935413432694401	1	0.402433141554453	0.935109430928819	0.0380726583876962
down	ISG15; IFITM1; IFITM3; IFITM2; ISG20; APOBEC3C;	GO:0045071~negative regulation of viral genome replication	6	43	13.953488372093	0.00030400176558154	0.00438612154358695	0.935413432694401	1	0.402433141554453	0.935109430928819	0.0380726583876962
down	FCN1; ANK2; PTPRK; JAM3; FBLN5;	GO:0034394~protein localization to cell surface	5	27	18.5185185185185	0.00030595830979673	0.00438860464756716	0.940821802624972	1	0.4035440441514	0.940821802624972	0.038094212366226
up	KLK8; CDH13; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00030643803918206	0.00999920645244091	0.446173785049089	0.459963496812282	0.29356764153642	0.446173785049089	0.0789080934786296
down	PDGFRB; BMP4; ENG; PTCH1;	GO:0048745~smooth muscle tissue development	4	14	28.5714285714286	0.0003068304096816	0.00438860464756716	0.943196679361245	1	0.403971701640732	0.943196679361245	0.038094212366226
up	PCDH7; CDH16; DSG3; CDH13; DSG1; DSG4; ROBO2; CDH3;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	8	165	4.84848484848485	0.00031488134293	0.010056104164637	0.45815235396316	0.47263689573794	0.297902401715709	0.45815235396316	0.0793570981085515
down	COL1A1; GLI1; COL6A1; BMP4; JUNB; IGFBP3; IGFBP5; FHL2; ITGA11;	GO:0001649~osteoblast differentiation	9	106	8.49056603773585	0.00033533325011725	0.00477560801029054	1	1	0.418495896146332	0.999750282688622	0.0414535006753702
down	GREM1; IGFBP5; ID1; ID2; ID3; PTCH1;	GO:0045668~negative regulation of osteoblast differentiation	6	44	13.6363636363636	0.00034000679648404	0.00480077972471495	1	1	0.420910345848411	0.999750282688622	0.0416719976036449
down	IFNG; INHBA; CD27; G0S2; FASLG; TNFRSF12A;	GO:0097191~extrinsic apoptotic signaling pathway	6	44	13.6363636363636	0.00034000679648404	0.00480077972471495	1	1	0.420910345848411	0.999750282688622	0.0416719976036449
down	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00034472095217763	0.00482609333048689	1	1	0.422972608321958	0.999750282688622	0.0418917261851579
down	PLAU; VIL1; TNFRSF12A;	GO:0061041~regulation of wound healing	3	5	60	0.00034472095217763	0.00482609333048689	1	1	0.422972608321958	0.999750282688622	0.0418917261851579
up	ALDH1A3; PRRX1; DLX5; WNT3A; USH1G;	GO:0042472~inner ear morphogenesis	5	57	8.7719298245614	0.0003485644706882	0.0108999014688125	0.506812740380652	0.523195270502998	0.315270796318233	0.506812740380652	0.0860158701692721
down	BMP4; ENG; TBX2; PARVA; ROBO1;	GO:0003148~outflow tract septum morphogenesis	5	28	17.8571428571429	0.00035504391860619	0.00488777127947856	1	1	0.427472878001853	0.999750282688622	0.0424271065795856
down	HBA1; PXDN; HBD; HBQ1; HBM;	GO:0042744~hydrogen peroxide catabolic process	5	28	17.8571428571429	0.00035504391860619	0.00488777127947856	1	1	0.427472878001853	0.999750282688622	0.0424271065795856
down	COL3A1; HRH2; FAT4; DCHS1; CLMP;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.00035504391860619	0.00488777127947856	1	1	0.427472878001853	0.999750282688622	0.0424271065795856
down	DEFA4; GNLY; DEFA3; S100A12; SPON2;	GO:0050832~defense response to fungus	5	28	17.8571428571429	0.00035504391860619	0.00488777127947856	1	1	0.427472878001853	0.999750282688622	0.0424271065795856
down	CYB561D2; ABCC4; PLOD3; CP; LDHB; AKR1B1; PAM; VCAM1; HSD17B2; LOXL1; SELENBP1; PDIA5; AOC3; P3H1; P3H3; LOXHD1; MSRB3; PXDN; GPX7; HEPH; MSRB1; FADS3; PTGES;	GO:0055114~oxidation-reduction process	23	526	4.37262357414449	0.00036012622998704	0.00493716624015435	1	1	0.429630592374545	0.999750282688622	0.042855867489468
down	RCAN2; NMUR1; PTGDR2; CCR2; CXCR5; ACKR3; CXCR3; CXCR1;	GO:0019722~calcium-mediated signaling	8	85	9.41176470588235	0.00037625086871973	0.00513691268698342	1	1	0.436451007714886	0.999750282688622	0.0445897178077289
down	MDK; FBLN1; ACVRL1; ARHGDIB; SEMA5A; TGFBI;	GO:0007162~negative regulation of cell adhesion	6	45	13.3333333333333	0.00037926438227464	0.00515674699191536	1	1	0.437755234605893	0.999750282688622	0.0447618846545723
up	ATP12A; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	3	12	25	0.00038028562003811	0.0116491574628001	0.552555005915377	0.570808715677206	0.329707632573043	0.552555005915377	0.0919285755718664
down	TESPA1; LCK; CD81; TRAT1;	GO:0050862~positive regulation of T cell receptor signaling pathway	4	15	26.6666666666667	0.00038288428993227	0.00516346813851522	1	1	0.439332332589154	0.999750282688622	0.0448202259285035
down	CLU; ACKR3; CXCL12; CDKN2D;	GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	4	15	26.6666666666667	0.00038288428993227	0.00516346813851522	1	1	0.439332332589154	0.999750282688622	0.0448202259285035
up	SLC6A15; SLC6A14; SLC6A1; SLC6A11;	GO:0006810~transport	4	32	12.5	0.00040559610263435	0.0119372500010621	0.588925541025081	0.608799750054165	0.339889534007588	0.588519944922447	0.0942020392759904
up	SCNN1B; SCNN1G; UGT1A7; ATP6V0A4;	GO:0007588~excretion	4	32	12.5	0.00040559610263435	0.0119372500010621	0.588925541025081	0.608799750054165	0.339889534007588	0.588519944922447	0.0942020392759904
down	SPRY1; GLI3; FBN1; ID2; ID3;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00040985497201573	0.00548243250016187	1	1	0.450840469217306	0.999750282688622	0.0475889182819059
down	TGFB1I1; THBS1; CDKN1C; DAB2; NPNT;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	5	29	17.2413793103448	0.00040985497201573	0.00548243250016187	1	1	0.450840469217306	0.999750282688622	0.0475889182819059
down	APP; PRKG1; TRAPPC4; MAP1A; LAMC2; MAP1B;	GO:0016358~dendrite development	6	46	13.0434782608696	0.00042197528086673	0.00555460688439722	1	1	0.456138034988328	0.999750282688622	0.0482154104226338
down	INHBA; BMP4; GATA1; SPI1; EPAS1; AHSP;	GO:0030218~erythrocyte differentiation	6	46	13.0434782608696	0.00042197528086673	0.00555460688439722	1	1	0.456138034988328	0.999750282688622	0.0482154104226338
down	PTGES; PDGFRB; HSD17B2; CDKN2D; PTCH1; IGFBP7;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.00042197528086673	0.00555460688439722	1	1	0.456138034988328	0.999750282688622	0.0482154104226338
down	TPM1; DMD; MAP2K3; KCNQ1; SCN1B; MYBPC3;	GO:0060048~cardiac muscle contraction	6	46	13.0434782608696	0.00042197528086673	0.00555460688439722	1	1	0.456138034988328	0.999750282688622	0.0482154104226338
up	NKX2-8; KRT4; PTN; SOX2; SFRP1;	GO:0050680~negative regulation of epithelial cell proliferation	5	60	8.33333333333333	0.00043443535761678	0.0125401436881305	0.629931268544331	0.652087471782787	0.351458204311975	0.629931268544331	0.0989597359635372
down	LCK; F3; F2R; FASLG; P2RX1; BEX3; DLC1; ROBO1;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	8	87	9.19540229885057	0.00043457871663887	0.0056978098403764	1	1	0.461522597070489	0.999750282688622	0.0494584487581937
down	PDLIM1; FSTL3; APOE; INHBA; JUNB; PAM; ZFP36L1; HLX; BRD3; TSC22D1; NFE4; OLIG1; THAP3; LITAF; MAGED1; VENTX; BATF; EPAS1; FOS; BATF2; BATF3; EGR2; EGR1; SPI1; TSHZ3; FOSB; SPIB; ATF3; MSC;	GO:0006357~regulation of transcription by RNA polymerase II	29	747	3.88219544846051	0.00044350569131701	0.00579186879095421	1	1	0.465237470191548	0.999750282688622	0.0502749045399288
up	GABRA4; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	3	13	23.0769230769231	0.00046467069100586	0.0126921888801734	0.672843160576491	0.697470707199802	0.363553299610077	0.672843160576491	0.100159590800394
up	PTPRZ1; GABRA4; NHLH2; KLK6; SH3GL3; ROBO2; SPINK5;	GO:0007417~central nervous system development	7	133	5.26315789473684	0.0004650702121316	0.0126921888801734	0.672956596954428	0.698070388409535	0.363684905886913	0.672956596954428	0.100159590800394
down	GREM1; UPK3A; CLU; HGF; EPB42; PSMB10; SLC39A3; NCKAP1L;	GO:0000902~cell morphogenesis	8	88	9.09090909090909	0.00046637835124063	0.00601490715533989	1	1	0.473374026509247	0.999750282688622	0.0522109346681915
down	SELP; VCAM1; CEACAM8; FAT4; DCHS1; CADM1;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	6	47	12.7659574468085	0.00046834632118031	0.00601490715533989	1	1	0.473975437549241	0.999750282688622	0.0522109346681915
down	IFNG; APOD; IGFBP3; IGFBP5; AIF1;	GO:0048662~negative regulation of smooth muscle cell proliferation	5	30	16.6666666666667	0.00047081198841214	0.00601490715533989	1	1	0.474809332508342	0.999750282688622	0.0522109346681915
down	MATN2; TYROBP; APOD; LGALS1; AIF1;	GO:0048678~response to axon injury	5	30	16.6666666666667	0.00047081198841214	0.00601490715533989	1	1	0.474809332508342	0.999750282688622	0.0522109346681915
down	INHBA; BMP4; CDKN1C; CDKN2D;	GO:0042326~negative regulation of phosphorylation	4	16	25	0.0004715075524313	0.00601490715533989	1	1	0.475019301755576	0.999750282688622	0.0522109346681915
down	PAM; P3H1; RHBDF1; RHBDD3;	GO:0050708~regulation of protein secretion	4	16	25	0.0004715075524313	0.00601490715533989	1	1	0.475019301755576	0.999750282688622	0.0522109346681915
up	KRT6A; DEFB1; LCE3A; PGLYRP3; RNASE7; GBP6;	GO:0050830~defense response to Gram-positive bacterium	6	95	6.31578947368421	0.00047578844558271	0.0127528295860653	0.687990092312605	0.714158456819654	0.368045761264375	0.687990092312605	0.100638133023908
down	ARHGAP6; CD3G; EPS8; SLA; GRAP; SKAP1; FCRL2;	GO:0009967~positive regulation of signal transduction	7	67	10.4477611940298	0.00048780527188818	0.00617512880581827	1	1	0.480020557386284	0.999750282688622	0.0536016996308942
down	SPRY1; ATF3; FBLN1; TIMP3; NLRP6; SPRY4; EMILIN1;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	7	67	10.4477611940298	0.00048780527188818	0.00617512880581827	1	1	0.480020557386284	0.999750282688622	0.0536016996308942
up	KLK8; EGFR; BMP7; WNT7B; NTF4;	GO:0048812~neuron projection morphogenesis	5	62	8.06451612903226	0.00049994192856295	0.0129381523236723	0.722416086773466	0.750412834772992	0.377714044937288	0.721916144844903	0.10210059546754
up	KRT6A; S100A7; DEFB1; PGLYRP3; RNASE7;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	5	62	8.06451612903226	0.00049994192856295	0.0129381523236723	0.722416086773466	0.750412834772992	0.377714044937288	0.721916144844903	0.10210059546754
down	ACTB; LAMA5; LAMA3;	GO:0001738~morphogenesis of a polarized epithelium	3	6	50	0.00050985128500369	0.00630917095749888	1	1	0.486907977178527	0.999750282688622	0.054765219838844
down	COL1A1; MMP2; CTSK;	GO:0001957~intramembranous ossification	3	6	50	0.00050985128500369	0.00630917095749888	1	1	0.486907977178527	0.999750282688622	0.054765219838844
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00050985128500369	0.00630917095749888	1	1	0.486907977178527	0.999750282688622	0.054765219838844
down	IFNG; FCER2; PRF1;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.00050985128500369	0.00630917095749888	1	1	0.486907977178527	0.999750282688622	0.054765219838844
down	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.00050985128500369	0.00630917095749888	1	1	0.486907977178527	0.999750282688622	0.054765219838844
down	C3; C2; CD300LF;	GO:2000427~positive regulation of apoptotic cell clearance	3	6	50	0.00050985128500369	0.00630917095749888	1	1	0.486907977178527	0.999750282688622	0.054765219838844
down	FN1; JUN; PDGFRB; PDGFRA; DDR2; PDGFD;	GO:0048146~positive regulation of fibroblast proliferation	6	48	12.5	0.0005185902945628	0.00639336691505785	1	1	0.489582689260109	0.999750282688622	0.05549606231503
down	APOE; THBS1; SPARC; PTPRM; ACVRL1;	GO:0001937~negative regulation of endothelial cell proliferation	5	31	16.1290322580645	0.00053834681786479	0.00658776994898258	1	1	0.495279072435615	0.999750282688622	0.0571835304407069
down	COL1A1; MMP2; RRAS; PDGFRA; CRISPLD2;	GO:0060325~face morphogenesis	5	31	16.1290322580645	0.00053834681786479	0.00658776994898258	1	1	0.495279072435615	0.999750282688622	0.0571835304407069
up	GABRR1; GABRA3; GABRE; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	4	35	11.4285714285714	0.0005534698604247	0.0133464753467418	0.798657008592849	0.830758260497482	0.399051769366212	0.798657008592849	0.10532285029617
up	ALDH1A3; CYP27C1; SDR16C5;	GO:0042574~retinal metabolic process	3	14	21.4285714285714	0.00056017851222167	0.0133464753467418	0.806657057599214	0.840827946844736	0.401730563125137	0.806096879086992	0.10532285029617
up	SCNN1B; SCNN1G; TFAP2B;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.00056017851222167	0.0133464753467418	0.806657057599214	0.840827946844736	0.401730563125137	0.806096879086992	0.10532285029617
down	DLL1; LAMA5; LAMA2; CXCR3; LAMA4; LAMA3;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.00057292584023827	0.00689416648579525	1	1	0.503601813569439	0.999750282688622	0.0598431308556335
up	SLPI; SCGB1A1; UGT1A1; GJB2; S100A7; BDKRB1; S100A14;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.0005734987872622	0.0134503387450089	0.824691256083051	0.86082167968057	0.407184138956166	0.824691256083051	0.10614248161176
down	NUPR1; WFS1; ID1; ID2; ID3; PTCH1; MAD2L2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	7	69	10.1449275362319	0.00057375593932806	0.00689416648579525	1	1	0.503757714730044	0.999750282688622	0.0598431308556335
down	MYH11; SMTN; MYLK; NMUR1;	GO:0006939~smooth muscle contraction	4	17	23.5294117647059	0.00057381833643876	0.00689416648579525	1	1	0.50381249939324	0.999750282688622	0.0598431308556335
down	A2M; SERPING1; GP9; GP5;	GO:0007597~blood coagulation, intrinsic pathway	4	17	23.5294117647059	0.00057381833643876	0.00689416648579525	1	1	0.50381249939324	0.999750282688622	0.0598431308556335
down	C7; GZMA; PRF1; GZMH;	GO:0019835~cytolysis	4	17	23.5294117647059	0.00057381833643876	0.00689416648579525	1	1	0.50381249939324	0.999750282688622	0.0598431308556335
down	TGM2; AXL; ACVRL1; CCR2; EPAS1;	GO:0001974~blood vessel remodeling	5	32	15.625	0.00061290202013264	0.00731057138815255	1	1	0.513188732879243	0.999750282688622	0.063457632059229
down	MFNG; TERT; APP; BMP4; B2M; SPON1; PLK2;	GO:0032092~positive regulation of protein binding	7	70	10	0.00062101933644553	0.00731101693373682	1	1	0.515193319507181	0.999750282688622	0.0634614995090153
down	EGR2; NR4A1; PSMB8; GRK5; NR4A2; CLIP3; RETN;	GO:0045444~fat cell differentiation	7	70	10	0.00062101933644553	0.00731101693373682	1	1	0.515193319507181	0.999750282688622	0.0634614995090153
down	RECK; GLI1; NR4A2; DIXDC1; WNT2B; NID1; PLPP3;	GO:0060070~canonical Wnt signaling pathway	7	70	10	0.00062101933644553	0.00731101693373682	1	1	0.515193319507181	0.999750282688622	0.0634614995090153
up	SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	3	15	20	0.00066737434482244	0.0153271302426361	0.959016933509856	1	0.434460698479413	0.959016933509856	0.120953060795122
up	PAX1; EDNRA; DLX5; WNT3A; OCA2; FAM83B; GRHL2;	GO:0008283~cell population proliferation	7	142	4.92957746478873	0.00067394443438639	0.0153271302426361	0.967784207778867	1	0.436042049047999	0.966840067058748	0.120953060795122
down	FTL; B2M; HEPH; CP;	GO:0006826~iron ion transport	4	18	22.2222222222222	0.00069094632171373	0.0079821211431545	1	1	0.532028667719577	0.999750282688622	0.0692868559324054
down	ACTB; LIMS2; FBLIM1; FERMT2;	GO:0034329~cell junction assembly	4	18	22.2222222222222	0.00069094632171373	0.0079821211431545	1	1	0.532028667719577	0.999750282688622	0.0692868559324054
down	GLI3; PDGFRA; ID2; HLX;	GO:0048557~embryonic digestive tract morphogenesis	4	18	22.2222222222222	0.00069094632171373	0.0079821211431545	1	1	0.532028667719577	0.999750282688622	0.0692868559324054
down	SERPINE1; CCR2; CXCL12; AIF1;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.00069094632171373	0.0079821211431545	1	1	0.532028667719577	0.999750282688622	0.0692868559324054
down	TERT; JUN; MMP2; IGFBP5; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	5	33	15.1515151515152	0.00069493022827615	0.00798949884996561	1	1	0.533011485087813	0.999750282688622	0.0693508963171309
down	BMP4; ACVRL1; SEMA5A;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	BMP4; SPI1; BATF;	GO:0002320~lymphoid progenitor cell differentiation	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	PLOD3; P3H3; P3H4;	GO:0017185~peptidyl-lysine hydroxylation	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	PTCH1; ARL13B; IFT140;	GO:0021532~neural tube patterning	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	RNASE2; RNASE3; SPON2;	GO:0043152~induction of bacterial agglutination	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	PDGFRB; PDGFRA; ACVRL1;	GO:0061298~retina vasculature development in camera-type eye	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	CSF1; CLU; IL34;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
down	AXL; CXCL12; LILRB1;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.00071818436998782	0.00798949884996561	1	1	0.538638277490872	0.999750282688622	0.0693508963171309
up	SCEL; EGFR; CDH3; DLX5; WNT3A; SFRP1; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	7	144	4.86111111111111	0.00072913673322916	0.0163348393518951	1	1	0.449853059628206	0.966840067058748	0.128905332304954
down	PGLYRP1; RNASE2; RNASE3; DEFA4; CAMP; GSDMD; DEFA3; RNASE6;	GO:0050830~defense response to Gram-positive bacterium	8	95	8.42105263157895	0.00074568586143786	0.00826760431607615	1	1	0.545096364711077	0.999750282688622	0.0717649229923513
down	TNFRSF13B; CD27; PSMB8; PSMB9; CD40LG; PSMB10; TNFRSF17; PLVAP; TNFRSF12A;	GO:0033209~tumor necrosis factor-mediated signaling pathway	9	120	7.5	0.00077500240471539	0.00856390617116947	1	1	0.552274455994173	0.999750282688622	0.0743368989844673
down	DDR2; FGFR1; LTK; PDGFRB; AXL; PDGFRA; FGFR4;	GO:0033674~positive regulation of kinase activity	7	73	9.58904109589041	0.00078157773485454	0.00860777611986471	1	1	0.553869955255685	0.999750282688622	0.0747177013752724
down	ADAMTS2; COL3A1; COL5A2; COL5A1; COL1A1;	GO:0043588~skin development	5	34	14.7058823529412	0.00078489350373134	0.0086155752037487	1	1	0.554677976340915	0.999750282688622	0.074785399420915
up	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.00078680385649543	0.0173675380676418	1	1	0.462493388535735	0.966840067058748	0.137054807684324
up	DKK1; BMP7; PRRX1; DLX5;	GO:0030326~embryonic limb morphogenesis	4	39	10.2564102564103	0.00080537904096045	0.0175199121808933	1	1	0.466338760624846	0.966840067058748	0.138257258181707
down	PACSIN1; MAD2L2; TPM2; TMOD1; RHOBTB2; MYO7B; TPM1; RHOBTB3; RHOBTB1;	GO:0007015~actin filament organization	9	121	7.43801652892562	0.00081899584815292	0.00883958564911066	1	1	0.562714803510779	0.999750282688622	0.0767298674610248
up	SNAI2; ID4; SOX2; DLX5; WNT3A; SFRP1;	GO:0001649~osteoblast differentiation	6	106	5.66037735849057	0.00082130639691246	0.0176111557395088	1	1	0.469846437148057	0.966840067058748	0.138977300845772
down	RNASE3; CAMP; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.0008240291706798	0.00883958564911066	1	1	0.564046653248032	0.999750282688622	0.0767298674610248
down	GLI3; ACVRL1; PKDCC; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	4	19	21.0526315789474	0.0008240291706798	0.00883958564911066	1	1	0.564046653248032	0.999750282688622	0.0767298674610248
down	IL2RA; MDK; CD27; PIK3R6;	GO:0045582~positive regulation of T cell differentiation	4	19	21.0526315789474	0.0008240291706798	0.00883958564911066	1	1	0.564046653248032	0.999750282688622	0.0767298674610248
down	LAMA5; LAMA2; LAMA4; LAMA3;	GO:0045995~regulation of embryonic development	4	19	21.0526315789474	0.0008240291706798	0.00883958564911066	1	1	0.564046653248032	0.999750282688622	0.0767298674610248
down	FCN1; IFITM1; IFITM3; IFITM2;	GO:0046597~negative regulation of viral entry into host cell	4	19	21.0526315789474	0.0008240291706798	0.00883958564911066	1	1	0.564046653248032	0.999750282688622	0.0767298674610248
down	BMP4; ID2; OLIG2; OLIG1;	GO:0048663~neuron fate commitment	4	19	21.0526315789474	0.0008240291706798	0.00883958564911066	1	1	0.564046653248032	0.999750282688622	0.0767298674610248
down	EGR2; OLIG2; LPAR1; JAM3; PMP22; MARVELD1;	GO:0042552~myelination	6	53	11.3207547169811	0.00083575389190504	0.00893634582153484	1	1	0.566765086273385	0.999750282688622	0.0775697705402331
down	PGLYRP1; DEFA4; GNLY; DEFA3; S100A12;	GO:0031640~killing of cells of other organism	5	35	14.2857142857143	0.00088326268160954	0.00935352532063438	1	1	0.578426769976349	0.999750282688622	0.0811909954419439
down	TERT; FOS; JUN; SPI1; EGR1;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	5	35	14.2857142857143	0.00088326268160954	0.00935352532063438	1	1	0.578426769976349	0.999750282688622	0.0811909954419439
down	APBB1; GREM1; SLIT2; INHBA; HSPA1B; ACVRL1; CDKN2D; FHL1; DCBLD2;	GO:0030308~negative regulation of cell growth	9	124	7.25806451612903	0.00096330503129626	0.0101169114429054	1	1	0.589559168272281	0.999750282688622	0.0878173825044791
down	MMP2; ACVRL1; RECK;	GO:0001955~blood vessel maturation	3	8	37.5	0.00097372210618762	0.0101169114429054	1	1	0.591049318455888	0.999750282688622	0.0878173825044791
down	MS4A1; ORAI1; ORAI3;	GO:0002115~store-operated calcium entry	3	8	37.5	0.00097372210618762	0.0101169114429054	1	1	0.591049318455888	0.999750282688622	0.0878173825044791
down	F2R; NLGN2; MYADM;	GO:0045217~cell-cell junction maintenance	3	8	37.5	0.00097372210618762	0.0101169114429054	1	1	0.591049318455888	0.999750282688622	0.0878173825044791
down	COL1A1; MMP2; FBN2;	GO:0060346~bone trabecula formation	3	8	37.5	0.00097372210618762	0.0101169114429054	1	1	0.591049318455888	0.999750282688622	0.0878173825044791
down	SELP; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.00097372210618762	0.0101169114429054	1	1	0.591049318455888	0.999750282688622	0.0878173825044791
down	SERPING1; ACVRL1; CXCL12; RCAN1; XCL2;	GO:0008015~blood circulation	5	36	13.8888888888889	0.00099051671129257	0.0102591448718203	1	1	0.59336439448072	0.999750282688622	0.0890520050968024
up	DKK1; ADH7; LYPD6; DKK4;	GO:2000272~negative regulation of signaling receptor activity	4	42	9.52380952380952	0.00104079422030401	0.0208297616623509	1	1	0.517845336908724	0.966840067058748	0.164376722113696
down	ARHGAP6; COL1A2; ARHGDIB; RHOBTB3; RHOBTB2; EPS8; RHOBTB1;	GO:0007266~Rho protein signal transduction	7	77	9.09090909090909	0.00104477147272852	0.010787265455922	1	1	0.600985588538271	0.999750282688622	0.0936362270309651
up	S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	3	18	16.6666666666667	0.00106445100887176	0.0210229074252172	1	1	0.522645445356033	0.966840067058748	0.16590091945713
down	SPRY1; SLIT2; FGFR1; BMP4; NPNT;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00110714199222239	0.0113956297268	1	1	0.609870800588335	0.999750282688622	0.0989169847186498
up	DSG1; CDH3; PKP1; CDH13;	GO:0007043~cell-cell junction assembly	4	43	9.30232558139535	0.00112895010904279	0.0220071962814705	1	1	0.532863010998659	0.966840067058748	0.173668371549316
down	GREM1; SLIT2; NR4A1; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.00114263014544447	0.0116520061745325	1	1	0.614735018249124	0.999750282688622	0.101142397949034
down	GLI1; PTCH1; TCTN1; IFT140;	GO:0008589~regulation of smoothened signaling pathway	4	21	19.047619047619	0.00114263014544447	0.0116520061745325	1	1	0.614735018249124	0.999750282688622	0.101142397949034
down	APOE; FCGR2B; TREML2; TREML4;	GO:0045088~regulation of innate immune response	4	21	19.047619047619	0.00114263014544447	0.0116520061745325	1	1	0.614735018249124	0.999750282688622	0.101142397949034
down	LAMA5; LRP4; NFIC; GLI3; BMP4; PDGFRA;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.0011829659700231	0.0120262140460194	1	1	0.620335503320753	0.999750282688622	0.104390618117018
up	SULT2B1; CYP2C9; UGT1A1; CYP2C19;	GO:0008202~steroid metabolic process	4	44	9.09090909090909	0.00122220742208412	0.0232496459567	1	1	0.544724361516514	0.966840067058748	0.183473083111359
up	ALOX12B; PSAPL1; ACER1;	GO:0006665~sphingolipid metabolic process	3	19	15.7894736842105	0.00122366557666842	0.0232496459567	1	1	0.544724361516514	0.966840067058748	0.183473083111359
down	TPM2; TPM1; DMD; TMOD1; MYBPC3;	GO:0030049~muscle filament sliding	5	38	13.1578947368421	0.00123363170744906	0.012426582809182	1	1	0.626684907384121	0.999750282688622	0.107865921525169
down	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.00128019485934483	0.0127787426443363	1	1	0.632416260516346	0.999750282688622	0.110922759090763
down	BPI; FCGR2B; CD200;	GO:0043031~negative regulation of macrophage activation	3	9	33.3333333333333	0.00128019485934483	0.0127787426443363	1	1	0.632416260516346	0.999750282688622	0.110922759090763
down	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.00128019485934483	0.0127787426443363	1	1	0.632416260516346	0.999750282688622	0.110922759090763
up	CDH16; CDH13; DSG1; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	4	45	8.88888888888889	0.00132072141923933	0.0238302246967306	1	1	0.556371721130801	0.966840067058748	0.18805468283209
down	FBN1; COL16A1; ITGA11; ITGB4;	GO:0033627~cell adhesion mediated by integrin	4	22	18.1818181818182	0.00133043439281655	0.0132402266080297	1	1	0.638608508551943	0.999750282688622	0.114928558092569
down	GREM1; FGFR1; FBN2; PBX1; PTCH1;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.00137048515651417	0.0135978467180865	1	1	0.643647905756079	0.999750282688622	0.118032792242822
up	FGF1; FGFR3; FGFBP1; ESRP1; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.00139661849904882	0.0238302246967306	1	1	0.565630492114771	0.966840067058748	0.18805468283209
up	SNAI2; PTHLH; EFEMP1;	GO:0032331~negative regulation of chondrocyte differentiation	3	20	15	0.00139710844324603	0.0238302246967306	1	1	0.565808806946938	0.966840067058748	0.18805468283209
down	TRPM2; FOS; JUN; ALOX15; JUNB; ALOX5AP; FOSB;	GO:0071277~cellular response to calcium ion	7	82	8.53658536585366	0.00146642167477951	0.0144628573536462	1	1	0.655490488626439	0.999750282688622	0.125541306109142
up	NKX2-8; EGFR; FGF1; PTN; WNT7B;	GO:0030324~lung development	5	80	6.25	0.00147221514777574	0.024553277075682	1	1	0.574316530581395	0.966840067058748	0.193760604094903
up	S100A7; DEFB1; LCE3A; IL22RA1; RNASE7;	GO:0050829~defense response to Gram-negative bacterium	5	80	6.25	0.00147221514777574	0.024553277075682	1	1	0.574316530581395	0.966840067058748	0.193760604094903
down	NUPR1; BMP4; CDKN1C; B2M; PTCH1; MAGED1;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.00150862717742883	0.0148348339113835	1	1	0.660759679866554	0.999750282688622	0.128770157902288
up	DKK1; SFRP1; MDFI; DKK4;	GO:0030178~negative regulation of Wnt signaling pathway	4	47	8.51063829787234	0.00153413858564799	0.0250298045332352	1	1	0.581438523960589	0.966840067058748	0.197521089823905
up	FGF1; PTN; BTC; GKN1;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.00153413858564799	0.0250298045332352	1	1	0.581438523960589	0.966840067058748	0.197521089823905
down	DLL1; APOE; DAB2; CLIP3;	GO:0045807~positive regulation of endocytosis	4	23	17.3913043478261	0.00153876003167452	0.0150416069368421	1	1	0.664362705119185	0.999750282688622	0.130565000722725
down	NEURL1; APOE; CAMK1; LPAR1;	GO:0060999~positive regulation of dendritic spine development	4	23	17.3913043478261	0.00153876003167452	0.0150416069368421	1	1	0.664362705119185	0.999750282688622	0.130565000722725
up	CLDN17; CLDN18; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	3	21	14.2857142857143	0.00158523316487247	0.0253131380901444	1	1	0.587020013666074	0.966840067058748	0.199756998333301
up	CYP2C9; CYP2C19; CYP2C18;	GO:0019373~epoxygenase P450 pathway	3	21	14.2857142857143	0.00158523316487247	0.0253131380901444	1	1	0.587020013666074	0.966840067058748	0.199756998333301
down	DLL1; COL1A2; ACVRL1; P2RX1; ACTA2; AGTRAP;	GO:0008217~regulation of blood pressure	6	61	9.83606557377049	0.00163104888236987	0.0157162394224184	1	1	0.675375376482105	0.999750282688622	0.136420983486847
down	GLI1; GLI3; PTCH1;	GO:0030850~prostate gland development	3	10	30	0.00164107221571863	0.0157162394224184	1	1	0.676755869565733	0.999750282688622	0.136420983486847
down	IGFBP3; IGFBP4; IGFBP5;	GO:0044342~type B pancreatic cell proliferation	3	10	30	0.00164107221571863	0.0157162394224184	1	1	0.676755869565733	0.999750282688622	0.136420983486847
down	PTPN6; ZFP36L1; FCRL3;	GO:0045577~regulation of B cell differentiation	3	10	30	0.00164107221571863	0.0157162394224184	1	1	0.676755869565733	0.999750282688622	0.136420983486847
down	HLA-G; CLEC12B; LILRB1;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.00164107221571863	0.0157162394224184	1	1	0.676755869565733	0.999750282688622	0.136420983486847
down	PDLIM4; PDLIM7; PDLIM1;	GO:0061061~muscle structure development	3	10	30	0.00164107221571863	0.0157162394224184	1	1	0.676755869565733	0.999750282688622	0.136420983486847
down	BMP4; AKR1B1; PTCH1;	GO:0072205~metanephric collecting duct development	3	10	30	0.00164107221571863	0.0157162394224184	1	1	0.676755869565733	0.999750282688622	0.136420983486847
up	ADGRL2; EGFR; MIF; EDN2; LIFR; ADGRF1; ADGRF4; ADGRF2; CBLC;	GO:0007166~cell surface receptor signaling pathway	9	268	3.35820895522388	0.00170015257880796	0.0268624107451657	1	1	0.600153860319209	0.966840067058748	0.211982983672014
down	ENC1; PSMB8; PSMB9; PSMB10;	GO:0010499~proteasomal ubiquitin-independent protein catabolic process	4	24	16.6666666666667	0.00176873835903002	0.0168899177405641	1	1	0.69249041155236	0.999750282688622	0.146608811895101
down	BMP4; ENG; EGR1; ACVRL1; ID1; FSTL1; GDF15;	GO:0030509~BMP signaling pathway	7	85	8.23529411764706	0.00177666341950855	0.0169167029915166	1	1	0.693301182194883	0.999750282688622	0.146841314733704
up	PTN; SOX2; KLK6;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.00178847600174059	0.0279635674855482	1	1	0.609870316593542	0.966840067058748	0.220672691142102
down	SNRPN; FHL2; MMP19; TIMP3; TIMP1;	GO:0009725~response to hormone	5	42	11.9047619047619	0.00184829868427805	0.0174479395795848	1	1	0.701497486113809	0.999750282688622	0.151452584380378
down	CA1; SLC4A1; CA4; CA6; HBA1;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.00184829868427805	0.0174479395795848	1	1	0.701497486113809	0.999750282688622	0.151452584380378
down	CXCR1; ACKR3; CD81; LILRB1; DNM1;	GO:0031623~receptor internalization	5	42	11.9047619047619	0.00184829868427805	0.0174479395795848	1	1	0.701497486113809	0.999750282688622	0.151452584380378
down	FOS; IGFBP5; PGF; FOSB; COL16A1; PAPPA; MAGED2;	GO:0007565~female pregnancy	7	86	8.13953488372093	0.00189065048772763	0.0177463329870798	1	1	0.706232382765762	0.999750282688622	0.154042715583037
up	EGFR; BTC; EFEMP1; FAM83B;	GO:0007173~epidermal growth factor receptor signaling pathway	4	50	8	0.00189754510413442	0.0290353164701655	1	1	0.622298644815817	0.966840067058748	0.229130329202286
down	SDC3; GPC4; APOE; AKR1B1; SDC2; HSPG2;	GO:0001523~retinoid metabolic process	6	63	9.52380952380952	0.00189837168856499	0.0177683287790899	1	1	0.707042697135317	0.999750282688622	0.154233644691326
down	TERT; WFS1; JUN; MDK; F2R; AXL; NR4A2; NAIP; APOE;	GO:0043524~negative regulation of neuron apoptotic process	9	138	6.52173913043478	0.00193357731015309	0.0178791800481552	1	1	0.711189227698276	0.999750282688622	0.155195862098443
down	ICAM2; PSMB8; PSMB9; ICAM3; PSMB10; MUC2; CLEC4C; CLEC4A;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	8	112	7.14285714285714	0.00199677466661896	0.0178791800481552	1	1	0.718171450130096	0.999750282688622	0.155195862098443
down	SDC3; GPC4; SDC2; HSPG2;	GO:0006027~glycosaminoglycan catabolic process	4	25	16	0.00202149144442831	0.0178791800481552	1	1	0.720907341368687	0.999750282688622	0.155195862098443
down	PDGFRB; BMP4; ENG; F2R;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.00202149144442831	0.0178791800481552	1	1	0.720907341368687	0.999750282688622	0.155195862098443
down	HGF; AXL; NNMT; CXCL12; PGF;	GO:0031100~animal organ regeneration	5	43	11.6279069767442	0.00203169914759793	0.0178791800481552	1	1	0.721834255340231	0.999750282688622	0.155195862098443
down	GATA1; PDGFRA; MYL9; PTPN6; ACTB;	GO:0070527~platelet aggregation	5	43	11.6279069767442	0.00203169914759793	0.0178791800481552	1	1	0.721834255340231	0.999750282688622	0.155195862098443
down	COL1A1; VIL1; ID1; ZFP36L1; SKAP1;	GO:0071364~cellular response to epidermal growth factor stimulus	5	43	11.6279069767442	0.00203169914759793	0.0178791800481552	1	1	0.721834255340231	0.999750282688622	0.155195862098443
down	GREM1; PTP4A3; APP; MMP8; CD27; TLR7;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	6	64	9.375	0.00204384405722402	0.0178791800481552	1	1	0.723520796257303	0.999750282688622	0.155195862098443
down	PRF1; CTSC; CADM1;	GO:0001913~T cell mediated cytotoxicity	3	11	27.2727272727273	0.0020595733915747	0.0178791800481552	1	1	0.724969833834294	0.999750282688622	0.155195862098443
down	COL1A1; COL1A2; ITGB4;	GO:0043589~skin morphogenesis	3	11	27.2727272727273	0.0020595733915747	0.0178791800481552	1	1	0.724969833834294	0.999750282688622	0.155195862098443
down	IFNG; APP; EGR1;	GO:0045080~positive regulation of chemokine biosynthetic process	3	11	27.2727272727273	0.0020595733915747	0.0178791800481552	1	1	0.724969833834294	0.999750282688622	0.155195862098443
down	GREM1; PMEPA1; EMILIN1;	GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation	3	11	27.2727272727273	0.0020595733915747	0.0178791800481552	1	1	0.724969833834294	0.999750282688622	0.155195862098443
down	LAMA5; FGFR1; TGM2;	GO:0060445~branching involved in salivary gland morphogenesis	3	11	27.2727272727273	0.0020595733915747	0.0178791800481552	1	1	0.724969833834294	0.999750282688622	0.155195862098443
up	S100A7; DEFB1; PGLYRP3; RNASE7;	GO:0019730~antimicrobial humoral response	4	52	7.69230769230769	0.00217044905996977	0.03208551634157	1	1	0.642386546518489	0.966840067058748	0.253200784965557
up	SCGB1A1; UGT1A1; SERPINB3; UGT1A7;	GO:0043086~negative regulation of catalytic activity	4	52	7.69230769230769	0.00217044905996977	0.03208551634157	1	1	0.642386546518489	0.966840067058748	0.253200784965557
down	NME4; APOD; CETP; PLTP; APOL4; ABCA6;	GO:0006869~lipid transport	6	65	9.23076923076923	0.00219757646315621	0.0189576831181936	1	1	0.734636973294223	0.999750282688622	0.164557544976494
down	GLI1; GLI3; BMP4; ARL3; PTCH1; ARL13B;	GO:0007224~smoothened signaling pathway	6	65	9.23076923076923	0.00219757646315621	0.0189576831181936	1	1	0.734636973294223	0.999750282688622	0.164557544976494
down	CD3G; CD8B; IRF4; TREML2; CD276;	GO:0042110~T cell activation	5	44	11.3636363636364	0.00222802839546954	0.0191703276526858	1	1	0.736821644214524	0.999750282688622	0.166403353999177
down	LAMA5; LAMA2; NEXN; LAMA4; LAMA3; RHOBTB1; RHOBTB2;	GO:0030334~regulation of cell migration	7	89	7.86516853932584	0.00226683967279295	0.0194536059192413	1	1	0.739073278228167	0.999750282688622	0.168862281907136
down	NUPR1; RHOBTB3; FSTL3; INHBA; PDGFRB; GATA1; WNT2B;	GO:0008584~male gonad development	7	90	7.77777777777778	0.00240425755141915	0.020579448056707	1	1	0.748169055874743	0.999750282688622	0.17863488001511
down	NUPR1; FOS; EGR2; EGR1; ATF3;	GO:0035914~skeletal muscle cell differentiation	5	45	11.1111111111111	0.00243780857304166	0.0207057057206417	1	1	0.750785031594585	0.999750282688622	0.179730828875634
down	IFNG; FCGR2B; MFGE8; IL15RA; SIRPG;	GO:0050766~positive regulation of phagocytosis	5	45	11.1111111111111	0.00243780857304166	0.0207057057206417	1	1	0.750785031594585	0.999750282688622	0.179730828875634
down	FAM107A; AIF1; EPS8; RHOBTB2; RHOBTB1;	GO:0051017~actin filament bundle assembly	5	45	11.1111111111111	0.00243780857304166	0.0207057057206417	1	1	0.750785031594585	0.999750282688622	0.179730828875634
up	PTHLH; FGFR3; GJB2; TFAP2C; GJB4; IL36G; CCL26; FGFBP1;	GO:0007267~cell-cell signaling	8	230	3.47826086956522	0.00245365943479203	0.0340002264459964	1	1	0.659208384830915	0.966840067058748	0.26831059639141
up	ALOX12B; KRT16; FLG2;	GO:0061436~establishment of skin barrier	3	25	12	0.00249302390536443	0.0340002264459964	1	1	0.661349676007686	0.966840067058748	0.26831059639141
down	TRPM2; IL18RAP; PDGFRB; AXL; PDGFD; MAP1LC3A;	GO:0070301~cellular response to hydrogen peroxide	6	67	8.95522388059701	0.00253099655061195	0.0212888066613188	1	1	0.756767968632974	0.999750282688622	0.18479229438664
down	TOX; ID2; AXL;	GO:0001779~natural killer cell differentiation	3	12	25	0.00253867730767543	0.0212888066613188	1	1	0.756999377349659	0.999750282688622	0.18479229438664
down	CSF1; EGR2; PBX1;	GO:0030278~regulation of ossification	3	12	25	0.00253867730767543	0.0212888066613188	1	1	0.756999377349659	0.999750282688622	0.18479229438664
down	THBS1; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.00253867730767543	0.0212888066613188	1	1	0.756999377349659	0.999750282688622	0.18479229438664
down	KCNQ1; HSPG2; MYLK;	GO:0072358~cardiovascular system development	3	12	25	0.00253867730767543	0.0212888066613188	1	1	0.756999377349659	0.999750282688622	0.18479229438664
down	ARHGAP6; PTPRK; FERMT2; DLC1;	GO:0048041~focal adhesion assembly	4	27	14.8148148148148	0.00259975066253015	0.0217457625037965	1	1	0.761416034244602	0.999750282688622	0.188758788136535
down	TYROBP; APP; SSTR3; PRKG1; DLC1;	GO:0030900~forebrain development	5	46	10.8695652173913	0.00266156337626655	0.0221506433128078	1	1	0.765278951123438	0.999750282688622	0.192273257258294
down	DLL1; CXCL14; SPARC; PDGFRB; KCNQ1;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00266156337626655	0.0221506433128078	1	1	0.765278951123438	0.999750282688622	0.192273257258294
up	PLA2G4E; PLA2G4F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.0027607683950519	0.0366717996546275	1	1	0.677390172636541	0.966840067058748	0.289393144240015
down	SOCS3; PGLYRP1; IL2RA; APOE; HGF; CNR2; SERPINF1;	GO:0050728~negative regulation of inflammatory response	7	93	7.52688172043011	0.00285520405852435	0.0237024980134785	1	1	0.77798738781178	0.999750282688622	0.205743753526772
down	TIMP1; COL1A1; SPARC; CXCL12; HHEX;	GO:0043434~response to peptide hormone	5	47	10.6382978723404	0.00289981742880396	0.0238820893319724	1	1	0.780753341679243	0.999750282688622	0.207302652168878
down	PPBP; OSM; MDK; PGF; PDGFD;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.00289981742880396	0.0238820893319724	1	1	0.780753341679243	0.999750282688622	0.207302652168878
down	SLIT2; BMP4; EMILIN1; ROBO1;	GO:0003180~aortic valve morphogenesis	4	28	14.2857142857143	0.00292743528433681	0.0238820893319724	1	1	0.782642953727311	0.999750282688622	0.207302652168878
down	SELP; VCAM1; CD40LG; CERCAM;	GO:0007159~leukocyte cell-cell adhesion	4	28	14.2857142857143	0.00292743528433681	0.0238820893319724	1	1	0.782642953727311	0.999750282688622	0.207302652168878
down	COL3A1; CXCL12; JUN; JUNB;	GO:0009314~response to radiation	4	28	14.2857142857143	0.00292743528433681	0.0238820893319724	1	1	0.782642953727311	0.999750282688622	0.207302652168878
down	NCKAP1L; SLC39A3; GPR174; SIT1;	GO:0043029~T cell homeostasis	4	28	14.2857142857143	0.00292743528433681	0.0238820893319724	1	1	0.782642953727311	0.999750282688622	0.207302652168878
down	CSF1; GATA1; F2R; CCR2;	GO:0048873~homeostasis of number of cells within a tissue	4	28	14.2857142857143	0.00292743528433681	0.0238820893319724	1	1	0.782642953727311	0.999750282688622	0.207302652168878
up	PLA2G4E; PLA2G4F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.00304556528733246	0.0400999429498774	1	1	0.694388885511802	0.966840067058748	0.316446116181972
down	PTGES; NUPR1; HP;	GO:0002526~acute inflammatory response	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	MCRIP1; GREM1; PHLDB1;	GO:0010717~regulation of epithelial to mesenchymal transition	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	PDGFRB; FGFR1; PDGFRA;	GO:0010863~positive regulation of phospholipase C activity	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	APOE; SERPINE1; TFPI;	GO:0030195~negative regulation of blood coagulation	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	GLI3; PTCH1; PKDCC;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	IGFBP3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	ID2; DAAM2; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	PLOD3; BMP4; ID1;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	FLRT2; NID1; MMP11;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	COL3A1; COL5A1; MFAP4;	GO:0097435~supramolecular fiber organization	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	APOE; CLU; SPON1;	GO:1902430~negative regulation of amyloid-beta formation	3	13	23.0769230769231	0.00308113233924756	0.0244713010790239	1	1	0.792681517732675	0.999750282688622	0.212417161044336
down	TPM1; MDK; TGM2; CXCL12; FUT7;	GO:0045785~positive regulation of cell adhesion	5	48	10.4166666666667	0.00315309566932731	0.024982801178555	1	1	0.797164132126659	0.999750282688622	0.216857112915527
down	PDLIM1; AIP; NUPR1; ID1; SCAND1; ID3; RBPMS;	GO:1903508~positive regulation of nucleic acid-templated transcription	7	95	7.36842105263158	0.00318999869024683	0.0252147264894151	1	1	0.798891499680875	0.999750282688622	0.218870284015345
up	ID4; WNT3A; DUOXA1; DUOXA2;	GO:0034613~cellular protein localization	4	59	6.77966101694915	0.0033374123714992	0.0408534911733811	1	1	0.708540581632074	0.966840067058748	0.322392693437247
up	FOXE1; TGM3; FOXQ1;	GO:0031069~hair follicle morphogenesis	3	28	10.7142857142857	0.00334775443992397	0.0408534911733811	1	1	0.709567273485132	0.966840067058748	0.322392693437247
down	TMEM150B; ITGB4; SRPX; IRF8; RAB39A; RAB24; CD84; WDR45;	GO:0006914~autophagy	8	123	6.50406504065041	0.00343755260517953	0.0256960945871338	1	1	0.812040259260235	0.999750282688622	0.223048682393287
up	EGFR; FGF1; MIF; TPD52L1;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.00353295865736336	0.042765894715342	1	1	0.718260820085048	0.966840067058748	0.337484302774013
down	SLIT2; EGR2; LAMC2; RHOBTB3;	GO:0008045~motor neuron axon guidance	4	30	13.3333333333333	0.00366523360831161	0.0271492089908877	1	1	0.824677561870113	0.999750282688622	0.235662087594802
down	S1PR2; APP; CHI3L1; CEMIP;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	4	30	13.3333333333333	0.00366523360831161	0.0271492089908877	1	1	0.824677561870113	0.999750282688622	0.235662087594802
down	PDGFRB; PDGFRA; PDGFD; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	4	30	13.3333333333333	0.00366523360831161	0.0271492089908877	1	1	0.824677561870113	0.999750282688622	0.235662087594802
up	SFRP1; KLK6; MARK1;	GO:0010975~regulation of neuron projection development	3	29	10.3448275862069	0.00366766081818504	0.0440412711047659	1	1	0.725397751922141	0.966840067058748	0.34754885337968
down	SERPINE1; THBS1; F2R;	GO:0030194~positive regulation of blood coagulation	3	14	21.4285714285714	0.00368946574966966	0.0271492089908877	1	1	0.826188987530294	0.999750282688622	0.235662087594802
down	DLL1; MMP8; FCGR2B;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.00368946574966966	0.0271492089908877	1	1	0.826188987530294	0.999750282688622	0.235662087594802
down	P2RY10; GPR171; P2RY13;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	3	14	21.4285714285714	0.00368946574966966	0.0271492089908877	1	1	0.826188987530294	0.999750282688622	0.235662087594802
down	CD276; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	3	14	21.4285714285714	0.00368946574966966	0.0271492089908877	1	1	0.826188987530294	0.999750282688622	0.235662087594802
down	NEURL1; VAMP5; HLX; COL19A1; MSC;	GO:0007519~skeletal muscle tissue development	5	50	10	0.00370682243907039	0.0272163140859746	1	1	0.826621403912697	0.999750282688622	0.236244577007357
down	COL1A1; THBS1; CHI3L1; TCL1A; AKAP12; ZFP36L1; NPNT; XCL2;	GO:0071356~cellular response to tumor necrosis factor	8	125	6.4	0.00376919736114745	0.0276129225747919	1	1	0.8297669017727	0.999750282688622	0.239687240271097
up	SLC6A1; GABRA4; GABRP; GABRQ; GABRE; CHRNB4; GABRA3; GABRR1;	GO:0007268~chemical synaptic transmission	8	249	3.21285140562249	0.00390704657622176	0.0464746848990403	1	1	0.737258408428389	0.966840067058748	0.366751981554308
down	PTP4A3; PTPRG; PTPRM; PTPN6; PTPRK; TNS2; PTPRN2;	GO:0035335~peptidyl-tyrosine dephosphorylation	7	99	7.07070707070707	0.00394863804551349	0.028863495801718	1	1	0.839968082841194	0.999750282688622	0.250542536182167
down	LITAF; CD276; BTNL3; BTNL8;	GO:0001817~regulation of cytokine production	4	31	12.9032258064516	0.00407741704320896	0.0295433901551807	1	1	0.846882032672519	0.999750282688622	0.256444193307231
down	S1PR4; LPAR1; NMUR1; ARHGAP6;	GO:0007202~activation of phospholipase C activity	4	31	12.9032258064516	0.00407741704320896	0.0295433901551807	1	1	0.846882032672519	0.999750282688622	0.256444193307231
down	SOCS3; IFNG; CCR2; IFNAR2;	GO:0007259~receptor signaling pathway via JAK-STAT	4	31	12.9032258064516	0.00407741704320896	0.0295433901551807	1	1	0.846882032672519	0.999750282688622	0.256444193307231
down	PTP4A3; STARD13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	4	31	12.9032258064516	0.00407741704320896	0.0295433901551807	1	1	0.846882032672519	0.999750282688622	0.256444193307231
down	HLA-G; PSMB8; PSMB9; PSMB10; B2M; FCGR1B;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	6	75	8	0.00425481330043742	0.0306272399665474	1	1	0.855795422049659	0.999750282688622	0.265852287269439
down	TSPAN4; NUPR1; VIL1; CD3G; LAMC1; NCKAP1L; SLC9A3R2; NFE4;	GO:0065003~protein-containing complex assembly	8	128	6.25	0.00431237119886529	0.0306920005737406	1	1	0.858929353474499	0.999750282688622	0.266414425926598
up	EGFR; EDNRA; NTF4;	GO:0007202~activation of phospholipase C activity	3	31	9.67741935483871	0.00436185256944666	0.049599550808632	1	1	0.759103102011452	0.966840067058748	0.391411659547261
up	SLPI; DEFB1; RNASE7;	GO:0019731~antibacterial humoral response	3	31	9.67741935483871	0.00436185256944666	0.049599550808632	1	1	0.759103102011452	0.966840067058748	0.391411659547261
down	SLIT2; BMP4; ROBO1;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	THBS1; CSF1; MDK;	GO:0010759~positive regulation of macrophage chemotaxis	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	DLL1; LAMB2; LAMC3;	GO:0014002~astrocyte development	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	PDGFRB; ITGA1; CD300A;	GO:0032516~positive regulation of phosphoprotein phosphatase activity	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	FOS; JUN; DMD;	GO:0035994~response to muscle stretch	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	IFNG; FCER2; AKAP12;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	BMP4; DAB2; RBPMS;	GO:0060391~positive regulation of SMAD protein signal transduction	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	HLA-G; ALOX5AP; SCARA5;	GO:0070207~protein homotrimerization	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	APP; CXCL12; AIF1;	GO:2000406~positive regulation of T cell migration	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	PDGFRB; HGF; FGFR4;	GO:2000573~positive regulation of DNA biosynthetic process	3	15	20	0.00436599281769312	0.0306920005737406	1	1	0.862150338550028	0.999750282688622	0.266414425926598
down	LRP4; GLI1; PTCH1; ARL13B;	GO:0009953~dorsal/ventral pattern formation	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	DLL1; LOXL3; SOX4; PLXDC1;	GO:0021510~spinal cord development	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	RECK; ID1; TNFRSF12A; PROK2;	GO:0045765~regulation of angiogenesis	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	BMP4; PDGFRA; IFT140; SLC39A3;	GO:0048701~embryonic cranial skeleton morphogenesis	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	GREM1; LRP4; PAM; SLC39A3;	GO:0060173~limb development	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	FAM107A; DIXDC1; PHLDB1; RASSF1;	GO:0070507~regulation of microtubule cytoskeleton organization	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	TERT; AIF1; ADAMTS1; CCND3;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	4	32	12.5	0.0045198008212648	0.0313069641791591	1	1	0.870608320942605	0.999750282688622	0.27175246752834
down	PDLIM1; APP; SCARA3; MSRB3; CYGB; PXDN; RBPMS;	GO:0006979~response to oxidative stress	7	102	6.86274509803922	0.00460184234705108	0.0318085504490727	1	1	0.874350045939705	0.999750282688622	0.276106364819286
down	CNR2; CCR2; NLGN2; NDN; PROK2;	GO:0019233~sensory perception of pain	5	53	9.43396226415094	0.00466316969578351	0.0320981514059765	1	1	0.877764382260079	0.999750282688622	0.278620175298858
down	LCK; LGALS1; PTPN6; CD40LG; ICOS;	GO:0031295~T cell costimulation	5	53	9.43396226415094	0.00466316969578351	0.0320981514059765	1	1	0.877764382260079	0.999750282688622	0.278620175298858
up	PRRX1; IRX5; GRHL2;	GO:0048701~embryonic cranial skeleton morphogenesis	3	32	9.375	0.00473671627054006	0.0534572264818093	1	1	0.777962806409252	0.966840067058748	0.421854258575207
down	BAG2; ID1; ACTB; DAB2; CAMK1; CARD16;	GO:0032091~negative regulation of protein binding	6	77	7.79220779220779	0.00479552759467716	0.0329405887168677	1	1	0.884834742126661	0.999750282688622	0.285932746925494
down	S1PR4; PF4; PTGER2; GPR65; ADGRE1; ADGRE3; PTGDR;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	7	103	6.79611650485437	0.00483670263392	0.0330847360706315	1	1	0.886668782843933	0.999750282688622	0.287183982875707
down	ARPC1B; COL1A1; PDGFRB; TFPI; PAM; MAP1B; PTCH1;	GO:0032355~response to estradiol	7	103	6.79611650485437	0.00483670263392	0.0330847360706315	1	1	0.886668782843933	0.999750282688622	0.287183982875707
down	APBB1; IFNG; THBS1; INHBA; CDKN1C; CDKN2D; LAMTOR4; RASSF1;	GO:0007050~cell cycle arrest	8	131	6.10687022900763	0.00491381777481847	0.0330847360706315	1	1	0.890420866143388	0.999750282688622	0.287183982875707
down	CACNA1H; TPM1; KCNQ1; TBX2;	GO:0008016~regulation of heart contraction	4	33	12.1212121212121	0.00499336431232178	0.0330847360706315	1	1	0.894289293111044	0.999750282688622	0.287183982875707
down	GREM1; GATA1; LTBP3;	GO:0030502~negative regulation of bone mineralization	3	16	18.75	0.00511282566665616	0.0332534960681731	1	1	0.900322197072508	0.999750282688622	0.288648862877791
down	PDLIM1; RHOBTB1; RHOBTB2;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.00511282566665616	0.0332534960681731	1	1	0.900322197072508	0.999750282688622	0.288648862877791
down	LCK; ALOX15; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	3	16	18.75	0.00511282566665616	0.0332534960681731	1	1	0.900322197072508	0.999750282688622	0.288648862877791
down	SPRY1; THBS1; SPRY4;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	3	16	18.75	0.00511282566665616	0.0332534960681731	1	1	0.900322197072508	0.999750282688622	0.288648862877791
down	UPK3A; SLC12A4; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.00511282566665616	0.0332534960681731	1	1	0.900322197072508	0.999750282688622	0.288648862877791
down	TERT; IGFBP5; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	3	16	18.75	0.00511282566665616	0.0332534960681731	1	1	0.900322197072508	0.999750282688622	0.288648862877791
up	BMP7; DLX5; SFRP1;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.0051304544675157	0.0566236187922137	1	1	0.797979002114465	0.966840067058748	0.44684163948466
down	FLRT2; RBFOX2; FGFR1; FGFR4; FAT4; SPRED2;	GO:0008543~fibroblast growth factor receptor signaling pathway	6	79	7.59493670886076	0.00538508855573028	0.0348543481976674	1	1	0.913457404030907	0.999750282688622	0.302544669377857
down	ADAMTS2; GLI3; F3; PTCH1; AEBP1;	GO:0016485~protein processing	5	55	9.09090909090909	0.0053906089373511	0.0348543481976674	1	1	0.913457404030907	0.999750282688622	0.302544669377857
down	LRP4; GLI3; BMP4; TBX2; IFT140;	GO:0042733~embryonic digit morphogenesis	5	55	9.09090909090909	0.0053906089373511	0.0348543481976674	1	1	0.913457404030907	0.999750282688622	0.302544669377857
down	BMP4; ENG; ACVRL1; NEO1;	GO:0030513~positive regulation of BMP signaling pathway	4	34	11.7647058823529	0.0054990624397897	0.0354169635498347	1	1	0.915776010656771	0.999750282688622	0.307428314733753
down	RBFOX2; LRP4; FARP1; SDC2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.0054990624397897	0.0354169635498347	1	1	0.915776010656771	0.999750282688622	0.307428314733753
up	OVOL1; KRT9; TFAP2B;	GO:0043588~skin development	3	34	8.82352941176471	0.00554332236720945	0.059859905562456	1	1	0.814868387979789	0.966840067058748	0.47238058802068
up	WNT3A; WNT7B; FZD10; BRINP1;	GO:0071300~cellular response to retinoic acid	4	69	5.79710144927536	0.00565275963035927	0.0606056586083519	1	1	0.819277609811247	0.966840067058748	0.4782656501341
up	WNT3A; WNT7B; SFRP1; FZD10;	GO:0060070~canonical Wnt signaling pathway	4	70	5.71428571428571	0.00593069908933275	0.0610157738387594	1	1	0.828339235944487	0.966840067058748	0.481502048051467
down	TRPM2; CXCR1; CCR2;	GO:0002407~dendritic cell chemotaxis	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	SLC16A2; CTSK; CPQ;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	PLAU; SERPINE1; FCGR2B;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	COL1A1; LGALS1; SPOCK1;	GO:0010812~negative regulation of cell-substrate adhesion	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	DPM2; PIGQ; PIGM;	GO:0016254~preassembly of GPI anchor in ER membrane	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	APOE; CETP; PLTP;	GO:0034375~high-density lipoprotein particle remodeling	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	APOE; CLU; CETP;	GO:0043691~reverse cholesterol transport	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	TOX; CXCR5; CD248;	GO:0048535~lymph node development	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	SLC4A1; GATA1; NCKAP1L;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	LCK; CCR2; SIRPG;	GO:0050870~positive regulation of T cell activation	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	THBS1; PDGFRB; AIF1;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	BMP4; BMP1; MDK;	GO:0061036~positive regulation of cartilage development	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	PDGFRB; CXCL12; TRPV2;	GO:0090280~positive regulation of calcium ion import	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
down	IFNG; APP; CLU;	GO:1902004~positive regulation of amyloid-beta formation	3	17	17.6470588235294	0.00593188180448412	0.0371896346907315	1	1	0.925159211298231	0.999750282688622	0.322815554259702
up	KLK8; BRINP1; CIDEA;	GO:0008219~cell death	3	35	8.57142857142857	0.00597556212811301	0.0610157738387594	1	1	0.830255122612658	0.966840067058748	0.481502048051467
up	EGFR; BTC; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	3	35	8.57142857142857	0.00597556212811301	0.0610157738387594	1	1	0.830255122612658	0.966840067058748	0.481502048051467
up	EDN2; NMU; PRKAA2;	GO:0097009~energy homeostasis	3	35	8.57142857142857	0.00597556212811301	0.0610157738387594	1	1	0.830255122612658	0.966840067058748	0.481502048051467
down	APP; MMP8; CD27; FCGR2B; SLAMF1; SH3RF3;	GO:0046330~positive regulation of JNK cascade	6	81	7.40740740740741	0.00602597375147862	0.037639570738933	1	1	0.927032003223936	0.999750282688622	0.326721114397343
down	VSTM1; CD300LF; IRF8; IRF4;	GO:0002376~immune system process	4	35	11.4285714285714	0.00603782460400559	0.037639570738933	1	1	0.927032003223936	0.999750282688622	0.326721114397343
down	TERT; PF4; HSPA1B; GATA1;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	4	35	11.4285714285714	0.00603782460400559	0.037639570738933	1	1	0.927032003223936	0.999750282688622	0.326721114397343
down	LAMB1; LAMC1; BMP4; ID1; HTRA1;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.00619470502238395	0.038544831250389	1	1	0.929949236800514	0.999750282688622	0.334579007495388
down	PLPP1; TGFB1I1; FHL2; PMEPA1;	GO:0030521~androgen receptor signaling pathway	4	36	11.1111111111111	0.00661055370654773	0.0400753424774923	1	1	0.935694111370201	0.999750282688622	0.347864236946732
down	FGFR1; LTBP4; EID1; PLEKHB1;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.00661055370654773	0.0400753424774923	1	1	0.935694111370201	0.999750282688622	0.347864236946732
down	SOCS3; JUN; FGFR1; JUNB;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.00661055370654773	0.0400753424774923	1	1	0.935694111370201	0.999750282688622	0.347864236946732
down	FN1; MAP1B; TNFRSF12A; TRPV2;	GO:0045773~positive regulation of axon extension	4	36	11.1111111111111	0.00661055370654773	0.0400753424774923	1	1	0.935694111370201	0.999750282688622	0.347864236946732
up	KRT16; MIF; PTN; SLURP1; SFRP1;	GO:0030336~negative regulation of cell migration	5	116	4.31034482758621	0.00672044104762715	0.0681579865708672	1	1	0.854020270007204	0.966840067058748	0.53786435965989
down	ENG; ACVRL1; TBX2;	GO:0003203~endocardial cushion morphogenesis	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	FSTL3; FUT7; SIRPG;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	F2R; NPNT; PROK2;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	CHRNB1; DMD; SGCB;	GO:0048747~muscle fiber development	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	SERPINH1; TSPAN33; TESC;	GO:0051604~protein maturation	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	EGR2; TIMP3; TBX21;	GO:0071310~cellular response to organic substance	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	TRPM2; SLC39A13; SLC39A3;	GO:0071577~zinc ion transmembrane transport	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	GREM1; WNT2B; MAGED1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	RNASE2; RNASE3; RNASE6;	GO:0090501~RNA phosphodiester bond hydrolysis	3	18	16.6666666666667	0.00682489238249429	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
down	APOE; TPM1; DMD; EPB42; MDK; ANK2; DPYSL2; PACSIN1;	GO:0007010~cytoskeleton organization	8	139	5.75539568345324	0.00683252265898426	0.0400753424774923	1	1	0.938435299752807	0.999750282688622	0.347864236946732
up	BMP7; SFRP1; ROBO2;	GO:0001657~ureteric bud development	3	37	8.10810810810811	0.00689906236002624	0.0690366173493293	1	1	0.8614988128936	0.966840067058748	0.544798017838651
up	EGFR; UGT1A1; SFRP1;	GO:0071392~cellular response to estradiol stimulus	3	37	8.10810810810811	0.00689906236002624	0.0690366173493293	1	1	0.8614988128936	0.966840067058748	0.544798017838651
down	FOS; JUN; BMP4; GDF15; INHBA;	GO:0060395~SMAD protein signal transduction	5	59	8.47457627118644	0.00707945410535826	0.0406791588940934	1	1	0.941567396012649	0.999750282688622	0.353105518094481
down	THBS1; SPARC; MAP1B; FEZ1; ACVRL1;	GO:0071363~cellular response to growth factor stimulus	5	59	8.47457627118644	0.00707945410535826	0.0406791588940934	1	1	0.941567396012649	0.999750282688622	0.353105518094481
down	LAMA5; LRP4; INHBA; APCDD1;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.00721812527360333	0.0411894402486794	1	1	0.943679564815291	0.999750282688622	0.357534890947399
down	FGFR1; BMP4; TGFBI; WNT2B;	GO:0002062~chondrocyte differentiation	4	37	10.8108108108108	0.00721812527360333	0.0411894402486794	1	1	0.943679564815291	0.999750282688622	0.357534890947399
down	HP; FN1; ORM1; ORM2;	GO:0006953~acute-phase response	4	37	10.8108108108108	0.00721812527360333	0.0411894402486794	1	1	0.943679564815291	0.999750282688622	0.357534890947399
down	FGFR1; AXL; ID2; EPAS1;	GO:0048469~cell maturation	4	37	10.8108108108108	0.00721812527360333	0.0411894402486794	1	1	0.943679564815291	0.999750282688622	0.357534890947399
down	SPARC; PAM; MDK; AIF1; PAPPA;	GO:0051384~response to glucocorticoid	5	60	8.33333333333333	0.00755329833114859	0.0430277546312327	1	1	0.947823263505624	0.999750282688622	0.37349193062371
down	APP; SPARC; MAP1LC3A;	GO:0010288~response to lead ion	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	APOE; PLTP; PTCH1;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	SOX4; OLIG2; PTCH1;	GO:0021522~spinal cord motor neuron differentiation	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	GATA1; PTPN6; CLEC1B;	GO:0030220~platelet formation	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	CST7; EGR2; HGF;	GO:0031643~positive regulation of myelination	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	PLOD3; APOE; ITGA1;	GO:0042311~vasodilation	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	SOCS3; PIK3R6; PIK3R5;	GO:0043551~regulation of phosphatidylinositol 3-kinase activity	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	APP; PDGFRB; PDGFD;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	CD53; GDF15; EHD2;	GO:1901741~positive regulation of myoblast fusion	3	19	15.7894736842105	0.00779341018157664	0.0437171939557372	1	1	0.95079604215235	0.999750282688622	0.37947644054211
down	APOE; APP; LAMB1; PTPRM; PTPRK; MICALL2; GPM6B;	GO:0031175~neuron projection development	7	115	6.08695652173913	0.00840878411584756	0.0470891910487463	1	1	0.958601389206621	0.999750282688622	0.408746238957557
up	SCGB1A1; DUOXA1; DUOXA2; ACE2;	GO:0050727~regulation of inflammatory response	4	78	5.12820512820513	0.00848618982522498	0.0811322989023101	1	1	0.902315358251797	0.966840067058748	0.640250309498991
down	IFNG; CLU; MMP8; AIF1;	GO:0045429~positive regulation of nitric oxide biosynthetic process	4	39	10.2564102564103	0.00854115641159847	0.0477495444736402	1	1	0.960536131087565	0.999750282688622	0.414478275817751
down	DLL1; SOCS3; IFNG; OSM; NDN;	GO:0040008~regulation of growth	5	62	8.06451612903226	0.00856632078468733	0.0478093308658901	1	1	0.960536131087565	0.999750282688622	0.414997237015188
down	LAMC1; BMP4; EXT1;	GO:0007492~endoderm development	3	20	15	0.00883881733319691	0.0489990813236285	1	1	0.963953785417682	0.999750282688622	0.425324575711561
down	NCKAP1L; PARVA; PARVG;	GO:0030031~cell projection assembly	3	20	15	0.00883881733319691	0.0489990813236285	1	1	0.963953785417682	0.999750282688622	0.425324575711561
down	GREM1; BMP4; LTBP3;	GO:0032331~negative regulation of chondrocyte differentiation	3	20	15	0.00883881733319691	0.0489990813236285	1	1	0.963953785417682	0.999750282688622	0.425324575711561
down	KCNQ1; ANK2; SCN1B;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	3	20	15	0.00883881733319691	0.0489990813236285	1	1	0.963953785417682	0.999750282688622	0.425324575711561
down	DLL1; ENG; TBX2; ARL13B; TBX21;	GO:0001947~heart looping	5	63	7.93650793650794	0.00910643600172067	0.0490079562033908	1	1	0.96758958789653	0.999750282688622	0.425401611940964
up	PTN; GJB2; DSG1;	GO:0032570~response to progesterone	3	42	7.14285714285714	0.00956138524214023	0.089697745302828	1	1	0.916460442458106	0.966840067058748	0.707843977903874
down	NCKAP1L; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	3	21	14.2857142857143	0.00996233278337422	0.052833944648906	1	1	0.978525179848414	0.999750282688622	0.458612171574076
down	PLPP1; PLPP3; FUT7;	GO:0006672~ceramide metabolic process	3	21	14.2857142857143	0.00996233278337422	0.052833944648906	1	1	0.978525179848414	0.999750282688622	0.458612171574076
down	ENG; LTBP4; DKK3;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	3	21	14.2857142857143	0.00996233278337422	0.052833944648906	1	1	0.978525179848414	0.999750282688622	0.458612171574076
down	APOE; THBS1; ACVRL1;	GO:0043537~negative regulation of blood vessel endothelial cell migration	3	21	14.2857142857143	0.00996233278337422	0.052833944648906	1	1	0.978525179848414	0.999750282688622	0.458612171574076
down	NCR3; IL18RAP; CADM1;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	3	21	14.2857142857143	0.00996233278337422	0.052833944648906	1	1	0.978525179848414	0.999750282688622	0.458612171574076
down	TERT; APOE; FCER2;	GO:0051000~positive regulation of nitric-oxide synthase activity	3	21	14.2857142857143	0.00996233278337422	0.052833944648906	1	1	0.978525179848414	0.999750282688622	0.458612171574076
down	EGR1; ID2; MAGED1; ID3; ID1;	GO:0032922~circadian regulation of gene expression	5	65	7.69230769230769	0.0102561600237779	0.0543050524335934	1	1	0.983169512574968	0.999750282688622	0.471381763930626
up	KLK8; PTN; ADGRF1; NTF4;	GO:0007613~memory	4	83	4.81927710843374	0.0104000842570434	0.0918266262930716	1	1	0.922019159229487	0.966840067058748	0.724643905076296
up	PTHLH; PTN; FGFR3;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.0107713151924341	0.0945482111335885	1	1	0.924350106542146	0.966840067058748	0.746121116495719
down	LDHB; AKR1B1; ALDH1B1; CHI3L1; CHI3L2; ST8SIA1; PIGQ;	GO:0005975~carbohydrate metabolic process	7	121	5.78512396694215	0.010787509891387	0.0568585553033497	1	1	0.989910653747686	0.999750282688622	0.493546822852528
down	TGFB1I1; CXCL12; IGFBP7; TRPV2;	GO:0009408~response to heat	4	42	9.52380952380952	0.0108072556690386	0.0568585553033497	1	1	0.989910653747686	0.999750282688622	0.493546822852528
down	FOS; THBS1; PTGER2; FOSB;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.0108072556690386	0.0568585553033497	1	1	0.989910653747686	0.999750282688622	0.493546822852528
down	FAM107A; CDKN2D; FHL1; KANK2;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	4	42	9.52380952380952	0.0108072556690386	0.0568585553033497	1	1	0.989910653747686	0.999750282688622	0.493546822852528
down	LOXL1; LTBP1; ROBO1;	GO:0035904~aorta development	3	22	13.6363636363636	0.0111650195066813	0.0586474156598964	1	1	0.993686736094631	0.999750282688622	0.509074588916758
down	COL1A1; COL1A2; COL5A1; ANTXR1;	GO:0001568~blood vessel development	4	43	9.30232558139535	0.0116406470164617	0.058718622507465	1	1	0.997507326353789	0.999750282688622	0.509692682591409
down	RGS16; RGS5; GRK5; RGS2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	4	43	9.30232558139535	0.0116406470164617	0.058718622507465	1	1	0.997507326353789	0.999750282688622	0.509692682591409
up	SCGB1A1; PTHLH; ENDOU; PSG4;	GO:0007565~female pregnancy	4	86	4.65116279069767	0.0116719758944432	0.100112204671767	1	1	0.929578988351624	0.966840067058748	0.790029013018641
down	GREM1; IL18RAP; APP; HSPA1B; CLU; CD40LG; S100A12; CARD16;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	8	154	5.19480519480519	0.0118875712931551	0.059872767610647	1	1	0.998439378609815	0.999750282688622	0.51971095769086
up	EGFR; ITGB6; SERPINB3; ACE2;	GO:0046718~viral entry into host cell	4	87	4.59770114942529	0.012117097944784	0.101816055938261	1	1	0.932524837258372	0.966840067058748	0.803474845510412
down	TGFB1I1; FAM89B; HTRA1; PMEPA1; EMILIN1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	5	68	7.35294117647059	0.0121610897825033	0.0609715335984687	1	1	0.998732864611758	0.999750282688622	0.529248527885084
down	TGFB1I1; UPK3A; VIL1; TAGLN; ID3;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.0121610897825033	0.0609715335984687	1	1	0.998732864611758	0.999750282688622	0.529248527885084
down	OSM; GATA1; PSMB8; PSMB9; PSMB10;	GO:1902036~regulation of hematopoietic stem cell differentiation	5	68	7.35294117647059	0.0121610897825033	0.0609715335984687	1	1	0.998732864611758	0.999750282688622	0.529248527885084
down	ARHGDIB; KANK2; EPS8;	GO:0035023~regulation of Rho protein signal transduction	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	TRPM2; SELP; VCAM1;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	FOS; IFNG; CSF1;	GO:0045672~positive regulation of osteoclast differentiation	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	MDK; OLIG2; IL34;	GO:0048714~positive regulation of oligodendrocyte differentiation	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	CCR2; TSHZ3; NLGN2;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	AKR1B1; PAM; RGS2;	GO:0060135~maternal process involved in female pregnancy	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	FAM107A; SSTR3; ZFP36L1;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.0124477914780331	0.0617530075727047	1	1	0.999342126691741	0.999750282688622	0.536031922135401
down	FN1; ROPN1L; TLR8; TLR7;	GO:0001932~regulation of protein phosphorylation	4	44	9.09090909090909	0.012514187731843	0.0618965213563012	1	1	0.999658474310194	0.999750282688622	0.53727765853429
down	FOLR2; CCR2; S100A12; XCL2;	GO:0002548~monocyte chemotaxis	4	44	9.09090909090909	0.012514187731843	0.0618965213563012	1	1	0.999658474310194	0.999750282688622	0.53727765853429
up	SHROOM2; CDH13; CDH3; CAP2;	GO:0000902~cell morphogenesis	4	88	4.54545454545455	0.0125729471178953	0.101816055938261	1	1	0.934631048070927	0.966840067058748	0.803474845510412
down	COL1A1; LTK; SERPINF1; PTK7; TESC;	GO:0071300~cellular response to retinoic acid	5	69	7.2463768115942	0.0128458587425517	0.0634420288271912	1	1	0.999750282688622	0.999750282688622	0.550693059222595
up	PTHLH; PAX1; BMP7; FGFR3; DLX5;	GO:0001501~skeletal system development	5	137	3.64963503649635	0.0128559173528418	0.101816055938261	1	1	0.936863002812588	0.966840067058748	0.803474845510412
down	CTSK; CNPY3; TLR8; TLR7;	GO:0002224~toll-like receptor signaling pathway	4	45	8.88888888888889	0.0134285130061051	0.0661219179913136	1	1	0.999750282688622	0.999750282688622	0.573955183550112
down	PF4; THBS1; GATA1; MYL9;	GO:0045652~regulation of megakaryocyte differentiation	4	45	8.88888888888889	0.0134285130061051	0.0661219179913136	1	1	0.999750282688622	0.999750282688622	0.573955183550112
up	EGFR; MIF; BTC;	GO:0048146~positive regulation of fibroblast proliferation	3	48	6.25	0.0134456839126696	0.101816055938261	1	1	0.94047249212137	0.966840067058748	0.803474845510412
down	THBS1; SOX4; PRR16; RBMS3; SAMD4A;	GO:0045727~positive regulation of translation	5	70	7.14285714285714	0.0135562052869903	0.0666513426610357	1	1	0.999750282688622	0.999750282688622	0.578550725281467
up	CDH3; CCNO; ALDH3A1; SLC6A11; SFRP1; TFAP2B;	GO:0042493~response to drug	6	193	3.10880829015544	0.0136207863876441	0.101816055938261	1	1	0.94047249212137	0.966840067058748	0.803474845510412
down	IFITM1; IFITM3; IFITM2;	GO:0034341~response to interferon-gamma	3	24	12.5	0.0138114204088248	0.0676202491044547	1	1	0.999750282688622	0.999750282688622	0.586961081370177
down	IFNG; APP; ZBTB20;	GO:0045821~positive regulation of glycolytic process	3	24	12.5	0.0138114204088248	0.0676202491044547	1	1	0.999750282688622	0.999750282688622	0.586961081370177
up	PRKAA2; WNT3A; WNT7B; CPZ; MARK1; DKK4;	GO:0016055~Wnt signaling pathway	6	194	3.09278350515464	0.0139305145247525	0.101816055938261	1	1	0.943072876892212	0.966840067058748	0.803474845510412
down	PLPP3; SLIT2; IGFBP3; FBLN1; MYADM;	GO:0001933~negative regulation of protein phosphorylation	5	71	7.04225352112676	0.0142925235612806	0.0676202491044547	1	1	0.999750282688622	0.999750282688622	0.586961081370177
down	EGR1; PSMB8; PSMB9; PSMB10; EPAS1;	GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia	5	71	7.04225352112676	0.0142925235612806	0.0676202491044547	1	1	0.999750282688622	0.999750282688622	0.586961081370177
down	BMP4; HGF; PGF; SEMA5A;	GO:0050918~positive chemotaxis	4	46	8.69565217391304	0.0143842264349774	0.0677001198592098	1	1	0.999750282688622	0.999750282688622	0.587654379978239
up	UPK1B; LY6G6C; ADH7; DEFB1;	GO:0009617~response to bacterium	4	92	4.34782608695652	0.014505292195655	0.101816055938261	1	1	0.945846620647778	0.966840067058748	0.803474845510412
down	MS4A1; VCAM1; CD40LG; HHEX; CD79B;	GO:0030183~B cell differentiation	5	72	6.94444444444444	0.0150551975468038	0.0707572869056044	1	1	0.999750282688622	0.999750282688622	0.614191372953659
up	SNAI2; GJB2; USH1G; ATP6V0A4; SLC52A3;	GO:0007605~sensory perception of sound	5	143	3.4965034965035	0.0151341736288837	0.101816055938261	1	1	0.950372202564753	0.966840067058748	0.803474845510412
down	APOD; CLU; ALOX15; PLTP; HSPG2; PTPRN2; APOL4;	GO:0006629~lipid metabolic process	7	130	5.38461538461539	0.0152201908790018	0.0711971971891107	1	1	0.999750282688622	0.999750282688622	0.618009906885911
down	HGF; CD40LG; TIGIT;	GO:0032733~positive regulation of interleukin-10 production	3	25	12	0.0152565422548094	0.0711971971891107	1	1	0.999750282688622	0.999750282688622	0.618009906885911
down	TERT; SPARC; B2M;	GO:0046686~response to cadmium ion	3	25	12	0.0152565422548094	0.0711971971891107	1	1	0.999750282688622	0.999750282688622	0.618009906885911
down	GLI1; FGFR1; TBX2;	GO:0060045~positive regulation of cardiac muscle cell proliferation	3	25	12	0.0152565422548094	0.0711971971891107	1	1	0.999750282688622	0.999750282688622	0.618009906885911
down	G0S2; TNFRSF12A; ITM2C;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	3	25	12	0.0152565422548094	0.0711971971891107	1	1	0.999750282688622	0.999750282688622	0.618009906885911
down	JUN; GRAP; RASSF1; PLK2; RRAS;	GO:0007265~Ras protein signal transduction	5	73	6.84931506849315	0.015844600818524	0.0738371806832205	1	1	0.999750282688622	0.999750282688622	0.640925639776934
down	FCGR2B; SSTR3; AIF1; LPAR1;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.0164220734246632	0.0764204656268833	1	1	0.999750282688622	0.999750282688622	0.663349214728238
up	CHRNB4; CLDN10; SLC9A4; SLC26A9;	GO:0006811~ion transport	4	96	4.16666666666667	0.0166157134770299	0.101816055938261	1	1	0.959075244712781	0.966840067058748	0.803474845510412
down	BAG2; CLU; DAB2; PLK2; HSPA1B;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	5	74	6.75675675675676	0.0166610963168297	0.0773251329079564	1	1	0.999750282688622	0.999750282688622	0.671201958434619
down	IGFBP3; IGFBP4; PDK4;	GO:0010906~regulation of glucose metabolic process	3	26	11.5384615384615	0.0167836635021767	0.0773251329079564	1	1	0.999750282688622	0.999750282688622	0.671201958434619
down	ID2; OLIG1; LPAR1;	GO:0014003~oligodendrocyte development	3	26	11.5384615384615	0.0167836635021767	0.0773251329079564	1	1	0.999750282688622	0.999750282688622	0.671201958434619
down	APP; THBS1; NCKAP1L;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.0167836635021767	0.0773251329079564	1	1	0.999750282688622	0.999750282688622	0.671201958434619
up	KLK6; MAL2; MALL;	GO:0042552~myelination	3	53	5.66037735849057	0.0172736974166524	0.101816055938261	1	1	0.963043831932283	0.966840067058748	0.803474845510412
up	CALML3; RNF180; CALML5;	GO:0050790~regulation of catalytic activity	3	53	5.66037735849057	0.0172736974166524	0.101816055938261	1	1	0.963043831932283	0.966840067058748	0.803474845510412
down	CSF1; SKAP1; NINJ1;	GO:0001954~positive regulation of cell-matrix adhesion	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	COL1A1; NR4A1; ZFP36L1;	GO:0044344~cellular response to fibroblast growth factor stimulus	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	MAP1B; NDN; SEMA5A;	GO:0048675~axon extension	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	ITGB4; ACTB; IER2;	GO:0048870~cell motility	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	LCK; CD8B; B2M;	GO:0050690~regulation of defense response to virus by virus	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	FOS; JUN; MAPK10;	GO:0051090~regulation of DNA-binding transcription factor activity	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	BMP4; PTK7; LTBP1;	GO:0060976~coronary vasculature development	3	27	11.1111111111111	0.018393167238371	0.081353446526878	1	1	0.999750282688622	0.999750282688622	0.706168752393156
down	HP; COL1A1; JUN; HBA1;	GO:0042542~response to hydrogen peroxide	4	50	8	0.0186319218849351	0.0822992913206225	1	1	0.999750282688622	0.999750282688622	0.714378927456058
up	KLK13; CPZ; CPXM2;	GO:0016485~protein processing	3	55	5.45454545454545	0.0189574896183331	0.101816055938261	1	1	0.966840067058748	0.966840067058748	0.803474845510412
up	WNT7B; WNT3A; SOX2;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.0189574896183331	0.101816055938261	1	1	0.966840067058748	0.966840067058748	0.803474845510412
down	PF4; CLU; SPON2; ZBTB20;	GO:0032760~positive regulation of tumor necrosis factor production	4	51	7.84313725490196	0.0198025179199808	0.0869471349477183	1	1	0.999750282688622	0.999750282688622	0.754723400561821
down	CSF1; SERPINF1; CD200; KIR3DL2;	GO:1901215~negative regulation of neuron death	4	51	7.84313725490196	0.0198025179199808	0.0869471349477183	1	1	0.999750282688622	0.999750282688622	0.754723400561821
down	SERPINE1; HSPA1B; TLR7;	GO:0032757~positive regulation of interleukin-8 production	3	28	10.7142857142857	0.0200853190142978	0.0869471349477183	1	1	0.999750282688622	0.999750282688622	0.754723400561821
down	MS4A1; CXCR5; FCRL1;	GO:0042113~B cell activation	3	28	10.7142857142857	0.0200853190142978	0.0869471349477183	1	1	0.999750282688622	0.999750282688622	0.754723400561821
down	P2RX1; ANK2; ORAI1;	GO:0051924~regulation of calcium ion transport	3	28	10.7142857142857	0.0200853190142978	0.0869471349477183	1	1	0.999750282688622	0.999750282688622	0.754723400561821
down	APBB1; APP; ACTB; MAP1A; MAP1B;	GO:0007409~axonogenesis	5	78	6.41025641025641	0.0202048756762481	0.0869471349477183	1	1	0.999750282688622	0.999750282688622	0.754723400561821
up	PLA2G4E; PLA2G4F; PLA2G3;	GO:0006644~phospholipid metabolic process	3	57	5.26315789473684	0.020728930441861	0.105950895377005	1	1	0.966840067058748	0.966840067058748	0.836104664536887
up	EGFR; DLX5; SFRP1;	GO:0050679~positive regulation of epithelial cell proliferation	3	57	5.26315789473684	0.020728930441861	0.105950895377005	1	1	0.966840067058748	0.966840067058748	0.836104664536887
up	PTHLH; ADGRF1; GPR78; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	4	103	3.88349514563107	0.0207508066807689	0.105950895377005	1	1	0.966840067058748	0.966840067058748	0.836104664536887
up	BMP7; PTN; GJB2; SLC6A1;	GO:0032355~response to estradiol	4	103	3.88349514563107	0.0207508066807689	0.105950895377005	1	1	0.966840067058748	0.966840067058748	0.836104664536887
down	BMP4; NR4A1; NR4A2; PAQR7;	GO:0043401~steroid hormone mediated signaling pathway	4	52	7.69230769230769	0.0210174564479431	0.0888000973196981	1	1	0.999750282688622	0.999750282688622	0.770807588538049
down	NUPR1; JUN; FASLG; ITGA1;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0210174564479431	0.0888000973196981	1	1	0.999750282688622	0.999750282688622	0.770807588538049
down	B2M; FCGRT; HLA-G;	GO:0001916~positive regulation of T cell mediated cytotoxicity	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
down	PLOD3; ZFP36L1; DCHS1;	GO:0021915~neural tube development	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
down	PGLYRP1; AXL; LILRB1;	GO:0032689~negative regulation of interferon-gamma production	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
down	GLI3; B2M; ZFP36L1;	GO:0033077~T cell differentiation in thymus	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
down	CDKN2D; HHEX; CDKN1C;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
down	CD19; F2R; CEMIP;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
down	FN1; RRAS; PTPN6;	GO:0070372~regulation of ERK1 and ERK2 cascade	3	29	10.3448275862069	0.0218602725035923	0.0915416227526858	1	1	0.999750282688622	0.999750282688622	0.794604731465823
up	DEFB1; GBP6; IFNE; WFDC12; S100A14; GSDMC;	GO:0042742~defense response to bacterium	6	216	2.77777777777778	0.022039504443493	0.111761135708389	1	1	0.966840067058748	0.966840067058748	0.881955801762904
down	DLL1; LCK; CCR2; AHSP;	GO:0030097~hemopoiesis	4	53	7.54716981132075	0.0222771190549984	0.0929338400981247	1	1	0.999750282688622	0.999750282688622	0.806689534603989
down	BAG2; ISG15; HSPA1B; SOX4;	GO:0031397~negative regulation of protein ubiquitination	4	53	7.54716981132075	0.0222771190549984	0.0929338400981247	1	1	0.999750282688622	0.999750282688622	0.806689534603989
down	IFNG; VIL1; CNPY4; CLIP3;	GO:1903078~positive regulation of protein localization to plasma membrane	4	53	7.54716981132075	0.0222771190549984	0.0929338400981247	1	1	0.999750282688622	0.999750282688622	0.806689534603989
up	DKK1; EGFR; PTPRZ1;	GO:0007611~learning or memory	3	59	5.08474576271187	0.0225881514615132	0.112640582537313	1	1	0.966840067058748	0.966840067058748	0.888895899751313
up	BMP7; ID4; SOX2;	GO:0045665~negative regulation of neuron differentiation	3	59	5.08474576271187	0.0225881514615132	0.112640582537313	1	1	0.966840067058748	0.966840067058748	0.888895899751313
down	FGFR1; BMP4; TCF4; CYB5D2; GPRC5B;	GO:0045666~positive regulation of neuron differentiation	5	81	6.17283950617284	0.0231633093175658	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
up	SCGB1A1; ALDH3A1; WNT7B;	GO:0051384~response to glucocorticoid	3	60	5	0.0235506884160536	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
down	THBS1; SPARC; RRAS; BMP4;	GO:0010595~positive regulation of endothelial cell migration	4	54	7.40740740740741	0.0235818560443366	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
down	IFNG; MMP1; CLU; TCL1A;	GO:0031334~positive regulation of protein-containing complex assembly	4	54	7.40740740740741	0.0235818560443366	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
down	APP; IGFBP5; KCNQ1; ZFP36L1;	GO:0071320~cellular response to cAMP	4	54	7.40740740740741	0.0235818560443366	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
down	BMX; EXT1; MEST;	GO:0007498~mesoderm development	3	30	10	0.0237180749652137	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
down	JUN; GZMA; ID1;	GO:0043392~negative regulation of DNA binding	3	30	10	0.0237180749652137	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
down	TERT; SERPINE1; SEMA5A;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.0237180749652137	0.096306098558644	1	1	0.999750282688622	0.999750282688622	0.835961601756368
down	PSMB8; PSMB9; PSMB10; PCBP4; ZFP36L1; SAMD4A;	GO:0043488~regulation of mRNA stability	6	112	5.35714285714286	0.0242803676336096	0.0974754977660343	1	1	0.999750282688622	0.999750282688622	0.846112286387283
up	FUT3; ACE2; TFAP2B; TFAP2C; GKN1;	GO:0042127~regulation of cell population proliferation	5	163	3.06748466257669	0.0246276251972261	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
down	CDKN2D; ACTB; SERTAD1; CCND3;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	4	55	7.27272727272727	0.0249319866624159	0.0999700047725997	1	1	0.999750282688622	0.999750282688622	0.867765246106455
up	GJB2; SLC6A1; SLC6A11; AQP5; OCA2; SLC25A21; GJB4;	GO:0055085~transmembrane transport	7	285	2.45614035087719	0.0249496410430854	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
up	KLK8; SOX2; KLK6;	GO:0009611~response to wounding	3	62	4.83870967741935	0.0255415714326245	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
down	DMD; ANK2; EPAS1;	GO:0002027~regulation of heart rate	3	31	9.67741935483871	0.0256586725158716	0.102386780184106	1	1	0.999750282688622	0.999750282688622	0.888743475671615
down	PDGFRB; CD19; PDGFRA;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.0256586725158716	0.102386780184106	1	1	0.999750282688622	0.999750282688622	0.888743475671615
down	GLI1; GLI3; PTCH1;	GO:0097421~liver regeneration	3	31	9.67741935483871	0.0256586725158716	0.102386780184106	1	1	0.999750282688622	0.999750282688622	0.888743475671615
down	WFS1; FGFR4; IGFBP5; SOX4; PTCH1; PDK4;	GO:0042593~glucose homeostasis	6	114	5.26315789473684	0.0260973542867249	0.104011650860481	1	1	0.999750282688622	0.999750282688622	0.902847769310325
up	FOXE1; BDKRB1; SHROOM2; ITGB6; PIK3C2G; EFS;	GO:0016477~cell migration	6	225	2.66666666666667	0.0261183807471597	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
down	PSMB8; PSMB9; PSMB10; FHL1;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	4	56	7.14285714285714	0.0263277993570327	0.104677556047697	1	1	0.999750282688622	0.999750282688622	0.908627996889406
down	DLL1; SERPINF1; LAMB2; LAMC3;	GO:0060041~retina development in camera-type eye	4	56	7.14285714285714	0.0263277993570327	0.104677556047697	1	1	0.999750282688622	0.999750282688622	0.908627996889406
up	AKR1B10; RBP1; ADH7;	GO:0001523~retinoid metabolic process	3	63	4.76190476190476	0.0265698797655622	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
up	FGF1; ANO1; SLC52A3;	GO:0034605~cellular response to heat	3	63	4.76190476190476	0.0265698797655622	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
up	SOX2; SFRP1; ELF5;	GO:0035019~somatic stem cell population maintenance	3	63	4.76190476190476	0.0265698797655622	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
up	SNAI2; EGFR; FGF1; SERPINB3; CDH13; CCL26;	GO:0030335~positive regulation of cell migration	6	226	2.65486725663717	0.0266004302917743	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
down	TYROBP; CSF1; JUNB;	GO:0030316~osteoclast differentiation	3	32	9.375	0.0276819152165015	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	NR4A1; NR4A2; DCBLD2;	GO:0030522~intracellular receptor signaling pathway	3	32	9.375	0.0276819152165015	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
up	ITGB6; COL4A5; SERPINB5; WNT3A; EGFL6; SPINK5;	GO:0030198~extracellular matrix organization	6	230	2.60869565217391	0.0285874989428941	0.113689413609008	1	1	0.966840067058748	0.966840067058748	0.897172682578257
down	ARPC1B; MMP2; SDC2; ACTB; DNM1;	GO:0048013~ephrin receptor signaling pathway	5	86	5.81395348837209	0.0286890156090949	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	MS4A1; PSMB10; CCR2; IFNG;	GO:0006959~humoral immune response	4	58	6.89655172413793	0.0292574725560032	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
up	PTPRZ1; SFRP1; SERPINB12;	GO:0002244~hematopoietic progenitor cell differentiation	3	66	4.54545454545455	0.0297859108508596	0.11673277333457	1	1	0.966840067058748	0.966840067058748	0.921189159771311
up	SNAI2; PRRX1; DLX5;	GO:0060021~roof of mouth development	3	66	4.54545454545455	0.0297859108508596	0.11673277333457	1	1	0.966840067058748	0.966840067058748	0.921189159771311
down	CNR2; RGS2; NR4A2;	GO:0001975~response to amphetamine	3	33	9.09090909090909	0.0297875619795986	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	LTK; ZFP36L1; PIK3R5;	GO:0014065~phosphatidylinositol 3-kinase signaling	3	33	9.09090909090909	0.0297875619795986	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	APP; IL1R1; CHI3L1;	GO:0070555~response to interleukin-1	3	33	9.09090909090909	0.0297875619795986	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	HSPA1B; NCAM1; AXL; CD81; SLAMF1;	GO:0046718~viral entry into host cell	5	87	5.74712643678161	0.0298855738555697	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
up	SLC9A4; OTOP3; ATP6V0A4; ATP12A;	GO:1902600~proton transmembrane transport	4	116	3.44827586206897	0.0299783215386088	0.117180887055864	1	1	0.966840067058748	0.966840067058748	0.924725420331299
down	AKAP12; OXER1; LPAR1; PTGDR2;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	4	59	6.77966101694915	0.0307917587299518	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	DLL1; DAAM2; IFT140; BICC1;	GO:0007368~determination of left/right symmetry	4	59	6.77966101694915	0.0307917587299518	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	APP; EGR2; B2M; LILRB2;	GO:0007611~learning or memory	4	59	6.77966101694915	0.0307917587299518	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	TRPM2; B2M; AQP10; UPB1;	GO:0051289~protein homotetramerization	4	59	6.77966101694915	0.0307917587299518	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	HSPA1B; CLU; BMP4; SOX4;	GO:0060548~negative regulation of cell death	4	59	6.77966101694915	0.0307917587299518	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	APP; OSM; TCL1A; CAMK1; MAD2L2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	5	88	5.68181818181818	0.0311130953623933	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	HP; BMP4; HBA1;	GO:0010942~positive regulation of cell death	3	34	8.82352941176471	0.031975285303192	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	IL11RA; PLVAP; MSC;	GO:0032502~developmental process	3	34	8.82352941176471	0.031975285303192	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	COL1A1; BMP4; HHEX;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.031975285303192	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	BMP4; IGFBP5; PKDCC;	GO:0048286~lung alveolus development	3	34	8.82352941176471	0.031975285303192	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	SLIT2; SOX4; ROBO1;	GO:0060412~ventricular septum morphogenesis	3	34	8.82352941176471	0.031975285303192	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
up	SCNN1B; SCNN1G; IRX5;	GO:0050896~response to stimulus	3	68	4.41176470588235	0.0320387633690076	0.122878245923476	1	1	0.966840067058748	0.966840067058748	0.969685760758822
down	JUNB; ENG; ACKR3; ZFP36L1;	GO:0001570~vasculogenesis	4	60	6.66666666666667	0.0323725790381169	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	CP; FTL; SCARA5; HEPH;	GO:0006879~cellular iron ion homeostasis	4	60	6.66666666666667	0.0323725790381169	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	LGALS1; SERPINF1; SOX4; ZBTB20;	GO:0071333~cellular response to glucose stimulus	4	60	6.66666666666667	0.0323725790381169	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
up	NTF4; EGFR; FGFR3; EFS;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	4	120	3.33333333333333	0.0332329662240629	0.122878245923476	1	1	0.966840067058748	0.966840067058748	0.969685760758822
down	IFNG; JUN; VIL1;	GO:0010634~positive regulation of epithelial cell migration	3	35	8.57142857142857	0.0342446758342778	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	FAM89B; FEZ1; JAM3;	GO:0030010~establishment of cell polarity	3	35	8.57142857142857	0.0342446758342778	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
up	SNAI2; DKK1; SOX2; SFRP1; DKK4;	GO:0090090~negative regulation of canonical Wnt signaling pathway	5	179	2.79329608938547	0.0344884739334101	0.122878245923476	1	1	0.966840067058748	0.966840067058748	0.969685760758822
down	PLPP1; FGFR4; G0S2; ID2; FHL2;	GO:0019216~regulation of lipid metabolic process	5	92	5.43478260869565	0.0363363408492537	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	LRP4; OSM; HGF; GATA1; CD81;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	5	92	5.43478260869565	0.0363363408492537	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	PSMB8; PSMB10; PSMB9;	GO:0010498~proteasomal protein catabolic process	3	36	8.33333333333333	0.0365952467702233	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	TERT; HHEX; DIXDC1;	GO:0030177~positive regulation of Wnt signaling pathway	3	36	8.33333333333333	0.0365952467702233	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	GLI1; SCUBE1; RAB34;	GO:0045880~positive regulation of smoothened signaling pathway	3	36	8.33333333333333	0.0365952467702233	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	FLRT2; SLIT2; SEMA3B;	GO:0050919~negative chemotaxis	3	36	8.33333333333333	0.0365952467702233	0.10652527988552	1	1	0.999750282688622	0.999750282688622	0.924666713047445
down	MAP1B; SDK1; NLGN2; FARP1;	GO:0007416~synapse assembly	4	63	6.34920634920635	0.0373954956677613	0.106881243673256	1	1	0.999750282688622	0.999750282688622	0.927756569895727
down	THBS1; HSPA1B; SCARA5; ST8SIA1;	GO:0034605~cellular response to heat	4	63	6.34920634920635	0.0373954956677613	0.106881243673256	1	1	0.999750282688622	0.999750282688622	0.927756569895727
up	SULT2B1; CYP11A1; CYP2C9;	GO:0008203~cholesterol metabolic process	3	73	4.10958904109589	0.038048424364914	0.122878245923476	1	1	0.966840067058748	0.966840067058748	0.969685760758822
down	PACSIN1; NLGN2; ACTB;	GO:0048488~synaptic vesicle endocytosis	3	37	8.10810810810811	0.0390264380997611	0.1114410021421	1	1	0.999750282688622	0.999750282688622	0.967336441267175
up	DUOXA1; DUOXA2; PHYHIP;	GO:0008104~protein localization	3	74	4.05405405405405	0.0393144953102013	0.125023426823331	1	1	0.966840067058748	0.966840067058748	0.986614317617749
down	F2R; MCAM; DKK3; FBN1; FBN2; SOX4;	GO:0009653~anatomical structure morphogenesis	6	127	4.7244094488189	0.0401127612141501	0.11231573139962	1	1	0.999750282688622	0.999750282688622	0.974929315261283
down	IL1R1; EGR1; PSMB8; PSMB9; PSMB10;	GO:0070498~interleukin-1-mediated signaling pathway	5	95	5.26315789473684	0.0405867475156196	0.113546667054706	1	1	0.999750282688622	0.999750282688622	0.98561415201913
up	NKX2-8; PTN; UGT1A1;	GO:0001889~liver development	3	75	4	0.0406017504907656	0.128347317288779	1	1	0.966840067058748	0.966840067058748	1
down	CTSK; MAP1LC3A; WDR45;	GO:0000422~autophagy of mitochondrion	3	38	7.89473684210526	0.0415376206913008	0.115814598113129	1	1	0.999750282688622	0.999750282688622	1
down	KCNQ1; ANK2; SCN1B;	GO:0086091~regulation of heart rate by cardiac conduction	3	38	7.89473684210526	0.0415376206913008	0.115814598113129	1	1	0.999750282688622	0.999750282688622	1
down	MDK; MYADM; LIMS2;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	3	38	7.89473684210526	0.0415376206913008	0.115814598113129	1	1	0.999750282688622	0.999750282688622	1
down	SERPINE1; HGF; FASLG;	GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	3	38	7.89473684210526	0.0415376206913008	0.115814598113129	1	1	0.999750282688622	0.999750282688622	1
up	EGFR; BMP7; ATP6V0A4;	GO:0001503~ossification	3	76	3.94736842105263	0.04191009685977	0.130564344575531	1	1	0.966840067058748	0.966840067058748	1
up	PTN; EDNRA; IRX4; FLRT3; PRICKLE4;	GO:0007507~heart development	5	190	2.63157894736842	0.0425039367410049	0.130564344575531	1	1	0.966840067058748	0.966840067058748	1
up	SCNN1B; SCNN1G; SLC6A15;	GO:0006814~sodium ion transport	3	77	3.8961038961039	0.043239436957762	0.130564344575531	1	1	0.966840067058748	0.966840067058748	1
up	CDH13; CDC42EP5; RND3;	GO:0007266~Rho protein signal transduction	3	77	3.8961038961039	0.043239436957762	0.130564344575531	1	1	0.966840067058748	0.966840067058748	1
up	FZD10; ARHGAP40; RND3;	GO:0032956~regulation of actin cytoskeleton organization	3	77	3.8961038961039	0.043239436957762	0.130564344575531	1	1	0.966840067058748	0.966840067058748	1
down	G0S2; CCR2; IRF4; EPAS1; TRPV2;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.0435806716801823	0.120768737950866	1	1	0.999750282688622	0.999750282688622	1
down	SOCS3; MSC; PTP4A3; EPS8; PCOLCE;	GO:1990830~cellular response to leukemia inhibitory factor	5	97	5.15463917525773	0.0435806716801823	0.120768737950866	1	1	0.999750282688622	0.999750282688622	1
down	RGS16; RGS5; IGFBP3;	GO:0009968~negative regulation of signal transduction	3	39	7.69230769230769	0.0441281002312717	0.120768737950866	1	1	0.999750282688622	0.999750282688622	1
down	THBS1; FGFR1; MAP2K3;	GO:0043536~positive regulation of blood vessel endothelial cell migration	3	39	7.69230769230769	0.0441281002312717	0.120768737950866	1	1	0.999750282688622	0.999750282688622	1
down	LILRA5; GREM1; GPRC5B;	GO:0061098~positive regulation of protein tyrosine kinase activity	3	39	7.69230769230769	0.0441281002312717	0.120768737950866	1	1	0.999750282688622	0.999750282688622	1
down	HRH2; DNM1; ANTXR1;	GO:1901998~toxin transport	3	39	7.69230769230769	0.0441281002312717	0.120768737950866	1	1	0.999750282688622	0.999750282688622	1
down	BMP4; NR4A2; SCUBE1; NDN;	GO:0009791~post-embryonic development	4	67	5.97014925373134	0.0447494302267167	0.122191832619068	1	1	0.999750282688622	0.999750282688622	1
down	SMARCA1; ID1; ID3; WNT2B; IER2; ITM2C;	GO:0030182~neuron differentiation	6	131	4.58015267175572	0.045224359694752	0.123386692346375	1	1	0.999750282688622	0.999750282688622	1
down	LGALS1; IGFBP3; EGR1; PTPN6; MAGED1; CLU; NME3; NME4;	GO:0042981~regulation of apoptotic process	8	202	3.96039603960396	0.0459121069484681	0.125159737093844	1	1	0.999750282688622	0.999750282688622	1
down	HGF; LOXL3; LOXL2;	GO:0001837~epithelial to mesenchymal transition	3	40	7.5	0.046797121017786	0.125719716240962	1	1	0.999750282688622	0.999750282688622	1
up	SCNN1B; SCNN1G; SHROOM2;	GO:0035725~sodium ion transmembrane transport	3	80	3.75	0.047352381653454	0.130564344575531	1	1	0.966840067058748	0.966840067058748	1
down	PAM; RCAN1; ID3; NDN; HPCAL4; TBX2;	GO:0007417~central nervous system development	6	133	4.51127819548872	0.0479252504841519	0.125719716240962	1	1	0.999750282688622	0.999750282688622	1
down	COL3A1; MDK; BCL2A1; FAT4;	GO:0021987~cerebral cortex development	4	69	5.79710144927536	0.0487077477618613	0.125719716240962	1	1	0.999750282688622	0.999750282688622	1
up	LIPK; PLA2G3; PNLIPRP3;	GO:0016042~lipid catabolic process	3	81	3.7037037037037	0.0487646384826725	0.132841601383832	1	1	0.966840067058748	0.966840067058748	1
up	DUOXA1; SH3GL3; BRINP1;	GO:0045666~positive regulation of neuron differentiation	3	81	3.7037037037037	0.0487646384826725	0.132841601383832	1	1	0.966840067058748	0.966840067058748	1
down	NCKAP1L; CD81; FCRL3;	GO:0030890~positive regulation of B cell proliferation	3	41	7.31707317073171	0.0495438696139414	0.125719716240962	1	1	0.999750282688622	0.999750282688622	1
down	SSTR3; FSTL1; PDK4;	GO:0042594~response to starvation	3	41	7.31707317073171	0.0495438696139414	0.125719716240962	1	1	0.999750282688622	0.999750282688622	1
down	APP; VCAM1; FCGR2B;	GO:1904646~cellular response to amyloid-beta	3	41	7.31707317073171	0.0495438696139414	0.125719716240962	1	1	0.999750282688622	0.999750282688622	1
